Omics of Covid-19 disease

Aktuelle Version vom 2. Dezember 2022, 20:07 Uhr

Maybe, specific information might be found in the raw readout of proteomic datasets.

Searchterm applied

(gives 9900 papers on june 7th 2022)

http://www.moremed.org/SiteSearch.php?S1=transcriptom*+OR+transcription*+OR+proteom*+OR+gene+expression+OR+interactom*+OR+omics+OR+hub+genes+OR+epigenom*+OR+dna+methylation+OR+metabolom*+OR+gene+chip+OR+transcripts+OR+microarray+OR+receptorom*+OR+glycom*+OR+differential+expression&S2=covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025

(additional 4493 papers) NOT SCANNED YET

http://www.moremed.org/SiteSearch.php?S1=gwas+OR+signature+OR+system+biology+OR+systems+biology+OR+atlas+OR+multiomic*&S2=%28covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+%29+AND+1995%3A2022%2F06%2F07%5BEDAT%5D&S3=transcriptom*+OR+transcription*+OR+proteom*+OR+gene+expression+OR+interactom*+OR+omics+OR+hub+genes+OR+epigenom*+OR+dna+methylation+OR+metabolom*+OR+gene+chip+OR+transcripts+OR+microarray+OR+receptorom*+OR+glycom*+OR+differential+expression&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025

14.500 papers were retrieved from about 200.000 covid papers. while reading the medline lists, papers were assigned to three classes:

a) dedicated databases or big datasets, some other db included, about 200 items

b) papers with very important topics, less than 100 items

c) other interesting papers, about 2500 items

Covid Omics Databases and Webservers

34845454 2021. Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics.
34127975 2021. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal.
34075382 2021. CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.
32587962 2020. The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions.
33206959 2020. The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.
33413085 2021. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection. [1]
34448623 2021. A Novel Pathway Network Analytics Method Based on Graph Theory.
33605735 2021. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
32930583 2020. Quantification of mRNA Expression Using Single-Molecule Nanopore Sensing.
33553941 2021. SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection. [2]
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
34718395 2022. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19.
34424948 2021. DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data.
34111889 2021. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects.
34076249 2021. Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.
34009288 2021. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
33592108 2021. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.
33416848 2021. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
33057582 2021. Web tools to fight pandemics: the COVID-19 experience.
34767776 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
33657410 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
34471261 2021. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
34348131 2021. The COVIDome Explorer researcher portal. [3]
33310371 2021. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review.
33301953 2021. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
35134150 2022. SCANNER: a web platform for annotation, visualization and sharing of single cell RNA-seq data.
33009914 2021. A database resource and online analysis tools for coronaviruses on a historical and global scale.
32404885 2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
33194800 2020. Systems Biology Approaches for Therapeutics Development Against COVID-19.
35003208 2021. COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets.
34975833 2021. Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
34907210 2021. Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2.
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
34557504 2021. Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses.
35047913 2021. The SIRAH-CoV-2 Initiative: A Coarse-Grained Simulations' Dataset of the SARS-CoV-2 Proteome.
35531299 2022. The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses.
33324374 2020. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
33585554 2020. SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.
34530086 2022. An overview of human proteins and genes involved in SARS-CoV-2 infection.
33263093 2021. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
34401607 2021. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
33553808 2020. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
33809949 2021. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
34209818 2021. Toward a Coronavirus Knowledge Graph.
35002537 2021. Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.
34001247 2021. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
34350693 2021. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.
34675627 2021. Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection.
34623759 2021. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
35269564 2022. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
32236644 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.
34522848 2021. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
34487344 2021. A pathway map of signaling events triggered upon SARS-CoV infection.
32806897 2020. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
35150462 2022. Thrombosis pathways in COVID-19 vs. influenza-associated ARDS: A targeted proteomics approach.
33413422 2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
34876157 2021. Multi-omics approach to COVID-19: a domain-based literature review.
32811513 2020. The current landscape of coronavirus-host protein-protein interactions.
34319784 2021. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
34106002 2021. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
35530264 2022. Plasma Proteomics of COVID-19-Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics.
34254058 2021. Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients.
35511435 2022. Single-cell transcriptomic profiling of lung endothelial cells identifies dynamic inflammatory and regenerative subpopulations.
35175937 2022. Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19.
34618691 2021. Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2.
33284134 2021. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity.
34642644 2021. A Pilot Study of Urine Proteomics in COVID-19-Associated Acute Kidney Injury.
35368565 2022. Single-Cell RNA Sequencing of Urinary Cells Reveals Distinct Cellular Diversity in COVID-19-Associated AKI.
35110370 2022. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
34425963 2021. Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury: A Multi-Omics Study.
35604092 2022. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.
34766152 2021. Application of omics technology to combat the COVID-19 pandemic.
33833618 2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
35547845 2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.
33758879 2021. The COVIDome Explorer Researcher Portal.
32743614 2020. Large-scale Multi-omic Analysis of COVID-19 Severity.
33398303 2020. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
33435351 2021. Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.
34153417 2021. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
34118193 2021. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
33989516 2021. The SARS-CoV-2 RNA interactome.
35504488 2022. Mapping molecular gene signatures mediated by SARS-COV-2 and large-scale and genome-wide transcriptomics comparative analysis among respiratory viruses of medical importance.
34400346 2021. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
34089862 2021. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
34664389 2021. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
35300459 2022. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
34876692 2021. A single-cell transcriptomic landscape of the lungs of patients with COVID-19.
34315893 2021. Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets.
34315889 2021. The trans-omics landscape of COVID-19.
33597532 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
34381043 2021. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.
33879890 2021. Single-cell multi-omics analysis of the immune response in COVID-19.
34876996 2021. Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19.
33915569 2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
33915568 2021. A molecular single-cell lung atlas of lethal COVID-19.
34237774 2021. Mapping the human genetic architecture of COVID-19.
33274348 2020. CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19.
34031419 2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
35100418 2022. AggMapNet: enhanced and explainable low-sample omics deep learning with feature-aggregated multi-channel networks.
34761257 2022. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions.
34718748 2022. MVIP: multi-omics portal of viral infection.
34634820 2022. SCovid: single-cell atlases for exposing molecular characteristics of COVID-19 across 10 human tissues.
34554255 2022. COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale.
35557984 2022. Weighted Gene Co-Expression Network Analysis to Identify Potential Biological Processes and Key Genes in COVID-19-Related Stroke.
34457122 2021. Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID-19.
32667665 2020. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
33842903 2021. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19.
33868814 2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.
32566414 2020. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33901166 2021. The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
34260589 2021. COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.
35468151 2022. Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity.
35390032 2022. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
35085325 2022. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
35377064 2022. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
34127904 2021. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
34031435 2021. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2.
33782412 2021. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.
34907210 2021. Identification of transcriptional regulatory network associated with response of ho
34376762 2021. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
33318519 2020. Gene expression network analysis provides potential targets against SARS-CoV-2.
33863870 2021. COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
33859163 2021. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
33846224 2021. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
33813307 2021. A SARS-CoV-2 -human metalloproteome interaction map.
33735949 2021. OverCOVID: an integrative web portal for SARS-CoV-2 bioinformatics resources.
34080738 2021. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
33162722 2020. A comprehensive overview of proteomics approach for COVID 19: new perspectives in target therapy strategies.
34550702 2021. Discovery Proteomics for COVID-19: Where We Are Now.
34379420 2021. A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients.
33666082 2021. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
34080435 2021. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage.
34077217 2021. Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response.
33464917 2021. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
33426872 2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
33103435 2020. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
32654489 2020. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
33245774 2021. PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies.
35511057 2022. deepHPI: a comprehensive deep learning platform for accurate prediction and visualization of host-pathogen protein-protein interactions.

2

33147627 2021. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.
32715315 2021. Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research.
34901953 2021. A call for discovery: Re-envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0-The COVID-19 Genome Atlas.
34181169 2021. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.
33070389 2021. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions.
32371892 2020. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.
32533075 2020. CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis.
33903708 2021. The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature.
35594018 2022. Databases, Knowledgebases, and Software Tools for Virus Informatics.
33843398 2021. Knowledge graphs and their applications in drug discovery.
34750573 2021. COVID-19 lung atlas.
32908256 2020. Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource.
35652743 2022. The Karolinska KI/K COVID-19 Immune Atlas: An open resource for immunological research and educational purposes.
35612186 2022. CovidGraph: Integrating COVID-19 Data.
33136473 2020. A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates.

related

• [Multiomic atlas with functional stratification and developmental dynamics of zebrafish cis-regulatory elements https://www.nature.com/articles/s41588-022-01089-w.pdf]

Other interesting papers

these were retrieved by the filtered omics search1 and two and they seem to be important

35310032 2022. Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice.
35184750 2022. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
34403366 2021. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.
32903321 2020. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
35339689 2022. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics.
34312385 2021. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
34262047 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
34116393 2021. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2).
33521378 2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. st epithelial cells to SARS-CoV-2.
35502829 2022. Bees can be trained to identify SARS-CoV-2 infected samples.
35543533 2022. Impaired exercise capacity in post-COVID syndrome: the role of VWF-ADAMTS13 axis.
35496775 2022. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination.
35211628 2022. 29 m(6)A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses.
33307139 2021. Total infectomes of 162 SARS-CoV-2 cases using meta-transcriptomic sequencing.
35291496 2022. SARS-CoV-2 infecting endothelial cells, biochemical alterations, autopsy findings and outcomes in COVID-19, suggest role of hypoxia-inducible factor-1.
33913550 2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
35064792 2022. Disturbed lipid and amino acid metabolisms in COVID-19 patients.
34626364 2022. Activation of STAT3 signaling pathway in the kidney of COVID-19 patients.
33724837 2021. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
34920080 2022. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
34835015 2021. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism.
33991451 2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
34673800 2021. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys.
33661927 2021. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes.
34108245 2021. HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.

2

33760431 2020. Pathology of COVID-19: Atlas
35195253 2022. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.
32685484 2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.
33269352 2020. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro.
32511374 2020. An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations.
34328172 2021. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
35307504 2022. Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish.
34382087 2021. Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data.
33993214 2021. Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries.
33636127 2021. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
32877699 2020. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
32526206 2020. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
35273357 2022. Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells.
35235832 2022. SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells.
33163980 2020. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells.
34749737 2021. The effect of vitamin D, magnesium and zinc supplements on interferon signaling pathways and their relationship to control SARS-CoV-2 infection.
34457214 2021. An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2.
34759959 2021. Prioritisation of Candidate Genes Underpinning COVID-19 Host Genetic Traits Based on High-Resolution 3D Chromosomal Topology.
34423108 2021. A network-based systems biology approach for identification of shared Gene signatures between male and female in COVID-19 datasets.
34598736 2021. A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome.
34904376 2022. The atomic portrait of SARS-CoV-2 as captured by cryo-electron microscopy.
33295606 2020. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity.
35420442 2022. Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
31826992 2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
34189540 2021. Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.
34184910 2021. Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways.
34788328 2021. Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
34582497 2021. Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium.
33203681 2020. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
33314005 2021. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
32671793 2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
33970408 2021. Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2.
33064832 2021. Commonalities Between COVID-19 and Radiation Injury.
34458775 2021. The chemical biology of coronavirus host-cell interactions.
34193418 2021. Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.
34045524 2021. Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.
33257774 2020. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
35632517 2022. The Existence of at Least Three Genomic Signature Patterns and at Least Seven Subtypes of COVID-19 and the End of the Disease.
35632715 2022. The International Virus Bioinformatics Meeting 2022.
34696455 2021. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
34580855 2022. Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells.
32908257 2020. Exploring the coronavirus pandemic with the WashU Virus Genome Browser.
32398875 2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.

Full Dataset

the two collections above are the most on-topic results. there were much more items of covid interest retrieved. anything e.g. about 2000 of 10000 primary results including the above contents will be shown here, the above items have been subtracted"

31744152 2019. A Multi-Omics Study of Chicken Infected by Nephropathogenic Infectious Bronchitis Virus.
31776274 2020. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle.
32071427 2020. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.
32102777 2020. The 2019 novel coronavirus resource.
32142596 2020. Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS.
32167747 2020. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
32188729 2020. Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
32194980 2020. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
32199615 2020. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
32218151 2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.
32223537 2020. Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation.
32227090 2020. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
32228827 2020. [Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].
32234303 2020. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.
32244779 2020. Master Regulator Analysis of the SARS-CoV-2/Human Interactome.
32272481 2020. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors.
32283711 2020. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.
32302675 2020. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses.
32303592 2020. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
32307550 2020. Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.
32311462 2020. On the molecular determinants of the SARS-CoV-2 attack.
32325252 2020. COVID-19 pathophysiology: A review.
32325642 2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2.
32327413 2020. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
32330414 2020. The Architecture of SARS-CoV-2 Transcriptome.
32344568 2020. RT-qPCR Testing of SARS-CoV-2: A Primer.
32345362 2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.
32353859 2020. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
32368569 2020. The molecular biology of intracellular events during Coronavirus infection cycle.
32374823 2020. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.
32376402 2020. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
32385990 2020. [Visualization analysis on treatment of coronavirus based on knowledge graph].
32391393 2020. Digesting the crisis: autophagy and coronaviruses.
32393985 2021. Therapeutic targets and signaling mechanisms of vitamin C activity against sepsis: a bioinformatics study.

32405156 2020. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
32407669 2020. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
32408336 2020. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
32437232 2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
32437596 2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
32444466 2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.
32452701 2020. An up-to-date overview of computational polypharmacology in modern drug discovery.
32458111 2020. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
32461193 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
32462744 2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
32463365 2020. Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors.
32463434 2021. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling.
32467561 2020. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
32468052 2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.
32473352 2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
32473977 2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
32475052 2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
32479746 2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
32481719 2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
32492406 2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
32494691 2020. Surviving COVID-19: A disease tolerance perspective.
32495654 2020. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
32496587 2020. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
32497778 2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.
32503824 2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.
32504168 2020. Impact of glycoscience in fighting Covid-19.
32510973 2020. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
32511305 2020. Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19.
32511326 2020. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium.
32511341 2020. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.
32511352 2020. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions.
32511361 2020. The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States.
32511372 2020. Nrf2 Activator PB125(R) as a Potential Therapeutic Agent Against COVID-19.
32511379 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
32511381 2020. An in silico map of the SARS-CoV-2 RNA Structurome.
32511382 2020. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium.
32511476 2020. Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2.
32511543 2020. Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease.
32511571 2020. COVID-19 infection results in alterations of the kynurenine pathway and fatty acid metabolism that correlate with IL-6 levels and renal status.
32511627 2020. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.
32511656 2020. Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19.
32512929 2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
32521790 2020. IGF-1 Deficiency Rescue and Intracellular Calcium Blockade Improves Survival and Corresponding Mechanisms in a Mouse Model of Acute Kidney Injury.
32522207 2020. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
32526370 2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
32526950 2020. Host Gene Expression of Macrophages in Response to Feline Coronavirus Infection.
32529795 2020. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.
32544429 2020. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.
32545518 2020. Nrf2 Activator PB125((R)) as a Potential Therapeutic Agent against COVID-19.
32547891 2020. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.
32554149 2020. Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy.
32559180 2020. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.
32561706 2020. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
32563676 2020. Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications.
32573711 2020. Platelet gene expression and function in patients with COVID-19.
32574283 2020. Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.
32574504 2020. Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.
32577056 2020. The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
32578378 2020. Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses.
32578831 2020. Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection.
32581017 2020. Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.
32582303 2020. Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study.
32587093 2020. Inhibition of SARS-CoV-2 by type I and type III interferons.
32587961 2021. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection.
32587963 2020. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 (+) T cells.
32591346 2020. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing.
32591762 2020. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.
32595353 2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks.
32596474 2020. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
32597823 2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
32599245 2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
32604797 2020. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.
32606886 2020. Hypercytokinemia and Pathogen-Host Interaction in COVID-19.
32608016 2020. Is susceptibility to severe COVID-19 disease an inborn error of metabolism?
32610096 2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
32615049 2021. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32617987 2021. Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review.
32619390 2020. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
32628270 2020. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
32629995 2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.
32632085 2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
32637948 2020. Genetic architecture of host proteins interacting with SARS-CoV-2.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.
32641214 2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
32641482 2020. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
32642770 2020. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.
32643596 2020. A review on histotechnology practices in COVID-19 pathology investigations.
32643603 2020. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32657586 2020. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.
32661197 2020. The molecular virology of coronaviruses.
32663409 2020. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.
32665542 2020. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
32665645 2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
32669265 2020. Discovery of M Protease Inhibitors Encoded by SARS-CoV-2.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32675206 2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
32676594 2020. Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies.
32676599 2020. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans.
32676602 2020. Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 + T cells.
32679150 2020. Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32686577 2021. Epigenetic mechanisms regulating COVID-19 infection.
32686937 2020. SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes.
32686993 2021. Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants.
32687176 2021. Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32694793 2020. A metabolic handbook for the COVID-19 pandemic.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
32698440 2020. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
32699064 2020. Viral subversion of nonsense-mediated mRNA decay.
32699094 2020. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
32699849 2020. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies.
32702714 2020. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702730 2020. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
32702734 2020. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32712910 2021. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
32714115 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
32714116 2020. Activation of the SARS-CoV-2 Receptor Ace2 by Cytokines Through Pan JAK-STAT Enhancers.
32720461 2020. An overview of the immune mechanisms of viral myocarditis.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32725480 2021. Prediction of the Receptorome for the Human-Infecting Virome.
32728199 2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32736569 2020. A modular framework for the development of targeted Covid-19 blood transcript profiling panels.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32741461 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?
32742242 2020. Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 (+) T Cells.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32750889 2021. AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32758273 2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32766585 2020. Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories.
32766588 2020. Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response.
32766608 2020. Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity.
32771622 2020. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.
32773100 2020. NK cells: A double edge sword against SARS-CoV-2.
32773420 2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32778874 2021. Pathogenetic profiling of COVID-19 and SARS-like viruses.
32779784 2021. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32782358 2020. The role of IgG Fc receptors in antibody-dependent enhancement.
32783921 2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
32786691 2020. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.
32788344 2020. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.
32788748 2020. Single-cell landscape of immunological responses in patients with COVID-19.
32790362 2020. Shell Disorder Analysis Suggests That Pangolins Offered a Window for a Silent Spread of an Attenuated SARS-CoV-2 Precursor among Humans.
32790936 2020. Nicotine and the nicotinic cholinergic system in COVID-19.
32793903 2020. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
32794723 2020. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
32799423 2020. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
32805023 2021. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
32809918 2020. Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
32810438 2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
32810597 2021. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.
32812012 2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
32814446 2021. COVID-19: fighting the invisible enemy with microRNAs.
32828489 2020. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.
32833213 2020. Proximity Labeling for the Identification of Coronavirus-Host Protein Interactions.
32833216 2020. Ribopuromycylation in Coronavirus-Infected Cells.
32835074 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
32835133 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
32838054 2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.
32838362 2021. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
32839745 2020. miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East.
32839770 2020. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.
32843695 2020. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
32851697 2021. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta.
32856216 2020. Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases.
32857620 2020. Azithromycin Downregulates Gene Expression of IL-1beta and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2.
32867123 2020. Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops.
32869031 2020. Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics.
32870373 2021. Why do SARS-CoV-2 NSPs rush to the ER?
32872332 2020. Delta9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
32872802 2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
32873700 2020. Gene of the month: TMPRSS2 (transmembrane serine protease 2).
32875809 2020. Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.
32878480 2020. Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium.
32880453 2020. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
32880920 2020. Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19.
32883081 2020. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.
32883368 2020. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
32883951 2020. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
32894568 2020. Three critical clinicobiological phases of the human SARS-associated coronavirus infections.
32895641 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
32898168 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
32902237 2020. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
32903570 2020. RNA-Seq-Based Whole Transcriptome Analysis of IPEC-J2 Cells During Swine Acute Diarrhea Syndrome Coronavirus Infection.
32908980 2020. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19.
32909006 2020. Cytotoxic lymphocytes are dysregulated in multisystem inflammatory syndrome in children.
32913009 2020. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
32913304 2021. Single-cell transcriptomic atlas of primate cardiopulmonary aging.
32914632 2020. Computational Immune Proteomics Approach to Target COVID-19.
32918943 2020. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
32924178 2021. The future is now? Clinical and translational aspects of "Omics" technologies.
32924263 2020. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
32927621 2020. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.
32929000 2020. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
32929138 2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
32931291 2020. Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases.
32935098 2020. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
32935119 2020. Kynurenic acid underlies sex-specific immune responses to COVID-19.
32936531 2020. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
32937650 2021. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study.
32938761 2020. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
32941612 2021. Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2.
32945158 2020. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
32946016 2020. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
32946807 2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
32948854 2020. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.
32959892 2021. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.
32960510 2020. Urinary Proteomics Associates with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study.
32966582 2020. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
32967859 2020. The pulmonary pathology of COVID-19.
32970329 2021. Genomic and proteomic mutation landscapes of SARS-CoV-2.
32971089 2020. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
32973879 2020. Single Cell RNA-seq Data Analysis Reveals the Potential Risk of SARS-CoV-2 Infection Among Different Respiratory System Conditions.
32974353 2020. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.
32974389 2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.
32975064 2020. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.
32979316 2020. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
32979740 2020. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.
32979938 2020. Evasion of Type I Interferon by SARS-CoV-2.
32983174 2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
32984567 2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.
32987033 2020. Transcription-based drug repurposing for COVID-19.
32987038 2020. Neprilysin expression and functions in development, ageing and disease.
32989935 2020. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.
32993015 2020. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
32995776 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
32995793 2021. Fixed single-cell RNA sequencing for understanding virus infection and host response.
32997660 2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
32998156 2020. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
32999036 2020. Single-Cell RNA Sequencing Reveals the Diversity of the Immunological Landscape following Central Nervous System Infection by a Murine Coronavirus.
33007239 2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
33008363 2020. Real-time audio and visual display of the Coronavirus genome.
33008459 2020. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
33009401 2020. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
33011745 2020. Predicting the response of the dental pulp to SARS-CoV2 infection: a transcriptome-wide effect cross-analysis.
33013423 2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.
33013872 2020. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19.
33014208 2020. How COVID-19 induces cytokine storm with high mortality.
33015591 2020. PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.
33017003 2021. VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data.
33024073 2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.
33024075 2020. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein.
33024578 2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.
33024988 2021. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
33033248 2020. Two distinct immunopathological profiles in autopsy lungs of COVID-19.
33033346 2020. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
33034007 2020. Combining fragment docking with graph theory to improve ligand docking for homology model structures.
33037188 2020. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
33037393 2020. An aberrant STAT pathway is central to COVID-19.
33038418 2021. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
33038424 2020. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
33040198 2021. SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation.
33040727 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
33041797 2020. In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis.
33042157 2020. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.
33043283 2020. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.
33046696 2020. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
33049061 2020. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.
33051211 2020. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
33053371 2021. A Sweep of Earth's Virome Reveals Host-Guided Viral Protein Structural Mimicry and Points to Determinants of Human Disease.
33055254 2020. The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. {
33060566 2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
33063674 2021. Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.
33067219 2020. Morphoproteomics Identifies the Vitamin D Receptor as a Potential Therapeutic Partner in Alveolar Pneumocytes for COVID-19 Infected Patients.
33067384 2020. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
33068412 2021. RASP: an atlas of transcriptome-wide RNA secondary structure probing data.
33068416 2020. Structural analysis of SARS-CoV-2 genome and predictions of the human interactome.
33071996 2020. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.
33072849 2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.
33077837 2020. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
33077915 2020. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.
33078621 2020. Epigenetic modifications of RNA and their implications in antiviral immunity.
33079314 2021. Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors.
33079950 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
33080218 2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
33083914 2021. Coronavirus: proteomics analysis of chicken kidney tissue infected with variant 2 (IS-1494)-like avian infectious bronchitis virus.
33084449 2020. Deep mutagenesis in the study of COVID-19: a technical overview for the proteomics community.
33086021 2021. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus(1).
33086697 2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
33087172 2020. The epigenetic implication in coronavirus infection and therapy.
33093657 2021. Self-amplifying RNA vaccines for infectious diseases.
33095583 2020. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses.
33096020 2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
33096026 2021. Large-Scale Multi-omic Analysis of COVID-19 Severity.
33097660 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
33097684 2020. Omics study reveals abnormal alterations of breastmilk proteins and metabolites in puerperant women with COVID-19.
33098359 2021. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
33100054 2020. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.
33103068 2020. Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal.
33103907 2020. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.
33106757 2020. Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives.
33106805 2021. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
33106807 2021. Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19.
33109704 2021. Antibody Binding Epitope Mapping (AbMap) of Hundred Antibodies in a Single Run.
33110916 2020. Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.
33111431 2021. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
33112126 2020. Targeting Crucial Host Factors of SARS-CoV-2.
33119313 2020. Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches.
33123533 2020. Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19.
33124193 2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
33125078 2021. Pfam: The protein families database in 2021.
33125711 2021. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
33126244 2021. Compositional diversity and evolutionary pattern of coronavirus accessory proteins.
33128875 2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
33128895 2020. Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.
33130005 2020. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
33131530 2020. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
33132111 2020. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.
33134953 2020. Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers.
33135055 2021. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
33135345 2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.
33137330 2021. Functional and druggability analysis of the SARS-CoV-2 proteome.
33138195 2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
33140059 2020. ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility.
33140861 2020. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage.
33141192 2020. Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
33141520 2020. Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?
33142113 2020. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
33143316 2020. Aprotinin Inhibits SARS-CoV-2 Replication.
33146070 2022. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
33146390 2021. Characterizing Transcriptional Regulatory Sequences in Coronaviruses and Their Role in Recombination.
33147444 2021. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
33147445 2021. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
33147460 2020. Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection.
33149541 2020. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
33151142 2021. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
33159154 2020. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.
33159646 2021. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
33161818 2021. The Circadian Clock and Viral Infections.
33161843 2021. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.
33164753 2020. Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes.
33165417 2020. Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period.
33171100 2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
33173052 2020. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
33173539 2020. Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis.
33173862 2021. The translational landscape of SARS-CoV-2 and infected cells.
33174592 2021. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
33175170 2021. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2021.
33177594 2020. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
33178176 2020. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.
33184616 2020. Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus.
33185982 2021. Interferon-stimulated gene products as regulators of central carbon metabolism.
33186585 2021. PolarProtDb: A Database of Transmembrane and Secreted Proteins showing Apical-Basal Polarity.
33188728 2020. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
33193639 2020. Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database.
33193717 2020. Integrative Network Analysis of Predicted miRNA-Targets Regulating Expression of Immune Response Genes in Bovine Coronavirus Infection.
33194826 2020. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.
33195414 2020. Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
33197212 2021. The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.
33199671 2020. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
33200082 2021. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.
33201004 2021. Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019.
33203833 2020. Immune suppression in the early stage of COVID-19 disease.
33203890 2020. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
33205948 2020. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry.
33207533 2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
33208736 2020. Architecture of a SARS-CoV-2 mini replication and transcription complex.
33209992 2020. nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks.
33211371 2021. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
33215473 2020. Deep learning applications to combat the dissemination of COVID-19 disease: a review.
33215503 2020. Saliva NMR-Based Metabolomics in the War Against COVID-19.
33217661 2021. Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.
33221483 2021. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.
33224264 2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.
33229438 2021. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.
33231169 2020. COVID-19 research risks ignoring important host genes due to pre-established research patterns.
33232865 2021. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
33234678 2021. Inhibiting the reproduction of SARS-CoV-2 through perturbations in human lung cell metabolic network.
33236003 2020. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2.
33237152 2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.
33237286 2021. UniProt: the universal protein knowledgebase in 2021.
33239293 2020. Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2.
33240326 2020. The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation.
33240937 2020. Molecular Basis of Cardiac and Vascular Injuries Associated With COVID-19.
33242255 2020. An integrative analysis identifying transcriptional features and key genes involved in COVID-19.
33242646 2021. Structural and functional insights into non-structural proteins of coronaviruses.
33244381 2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
33244583 2021. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
33245961 2021. Structural insights into SARS-CoV-2 proteins.
33247099 2020. SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication.
33253764 2021. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update.
33256749 2020. LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC.
33256807 2020. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.
33259809 2020. The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2.
33259812 2020. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
33259846 2021. Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
33260034 2021. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
33264393 2020. Translational control of coronaviruses.
33268501 2020. The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation.
33268519 2020. The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.
33269371 2020. Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysis.
33270107 2021. Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review.
33270111 2021. GENCODE 2021.
33271804 2020. Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease.
33277324 2021. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program.
33277638 2021. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
33277640 2021. Host genetics and infectious disease: new tools, insights and translational opportunities.
33279860 2021. Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study.
33279989 2021. Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities.
33282419 2021. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections.
33284859 2020. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.
33287945 2020. A comprehensive review of histopathological findings of infections induced by COVID-19.
33289002 2020. Enhancement of the IFN-beta-induced host signature informs repurposed drugs for COVID-19.
33289122 2021. Hidden in plain sight: The effects of BCG vaccination in the COVID-19 pandemic.
33291220 2020. The International Virus Bioinformatics Meeting 2020.
33291791 2020. Eosinopenia in COVID-19 Patients: A Retrospective Analysis.
33292131 2021. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
33292691 2020. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.
33293514 2020. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients.
33293527 2020. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.
33293627 2020. SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress.
33295922 2020. Understanding the relationship between viral infections and trace elements from a metallomics perspective: implications for COVID-19.
33296687 2020. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
33299987 2020. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types.
33299989 2020. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic.
33299992 2020. Transcriptional response modules characterise IL-1beta and IL-6 activity in COVID-19.
33300002 2020. Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity.
33300133 2021. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.
33301474 2020. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
33301685 2021. COVID-19: The Effect of Host Genetic Variations on Host-Virus Interactions.
33307546 2021. Genetic mechanisms of critical illness in COVID-19.
33309104 2021. Using Genetics To Dissect SARS-CoV-2 Infection.
33309308 2021. Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019.
33311431 2020. Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment.
33312453 2021. Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.
33312454 2020. L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies.
33312949 2020. Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2.
33313418 2020. Integrative vectors for regulated expression of SARS-CoV-2 proteins implicated in RNA metabolism.
33315853 2020. Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Cytokine Pathways Involved in COVID-19 After Rhinovirus Infection in Asthma Patients.
33318629 2021. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients.
33319166 2021. Transcriptional response modules characterize IL-1beta and IL-6 activity in COVID-19.
33319978 2021. Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic.
33322045 2020. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
33322535 2020. Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.
33325715 2021. Peptide Correlation Analysis (PeCorA) Reveals Differential Proteoform Regulation.
33326239 2020. Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.
33328453 2020. Genetic architecture of host proteins involved in SARS-CoV-2 infection.
33329483 2020. Rapid Scanning Electron Microscopy Detection and Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2 and Other Respiratory Viruses.
33329603 2020. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.
33329730 2020. Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2.
33330860 2020. Circular RNA profiling reveals abundant and diverse circRNAs of SARS-CoV-2, SARS-CoV and MERS-CoV origin.
33330870 2020. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome.
33330871 2020. Profound Treg perturbations correlate with COVID-19 severity.
33331649 2021. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.
33333024 2021. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
33333559 2021. Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease.
33341869 2021. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19.
33341900 2021. SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci.
33343631 2020. CRFK and Primary Macrophages Transcriptomes in Response to Feline Coronavirus Infection Differ Significantly.
33345622 2021. Increased expression of hypoxia-induced factor 1alpha mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients.
33346100 2021. Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
33347311 2021. Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication.
33349665 2021. The SARS-CoV-2 RNA-protein interactome in infected human cells.
33350309 2021. Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An In Silico Study.
33352107 2021. Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA.
33352703 2020. SARS-Cov-2 Interactome with Human Ghost Proteome: A Neglected World Encompassing a Wealth of Biological Data.
33352880 2020. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement.
33354650 2020. Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis.
33357411 2021. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
33357464 2021. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
33357513 2021. Host genetic effects in pneumonia.
33358567 2021. Biological functions of MAIT cells in tissues.
33359760 2021. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.
33359807 2021. SARS-Cov-2 ORF3a: Mutability and function.
33361761 2020. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19.
33362557 2020. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
33362771 2020. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
33364229 2020. Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay.
33364494 2020. Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2.
33364597 2021. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis.
33367597 2021. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.
33375876 2021. Progress in understanding COVID-19: insights from the omics approach.
33376242 2020. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
33377107 2020. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.
33377120 2020. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19.
33381809 2021. Improving gene network inference with graph wavelets and making insights about ageing-associated regulatory changes in lungs.
33382968 2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
33382973 2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
33390179 2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.
33391477 2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.
33392409 2021. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2.
33393161 2022. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.
33393790 2021. Metaproteomics Analysis of SARS-CoV-2-Infected Patient Samples Reveals Presence of Potential Coinfecting Microorganisms.
33394568 2021. Illuminating the immunopathology of SARS-CoV-2.
33395363 2021. Epigenetic mechanisms influencing COVID-19.
33396899 2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.
33397514 2021. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.
33397903 2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
33397975 2021. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2.
33398248 2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
33398261 2020. Broad Auto-Reactive IgM Responses Are Common In Critically Ill COVID-19 Patients.
33399506 2021. The RSNA International COVID-19 Open Radiology Database (RICORD).
33401144 2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.
33406224 2021. HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.
33407110 2021. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell.
33413329 2021. Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.
33413539 2021. HiDeF: identifying persistent structures in multiscale 'omics data.
33418085 2020. MicroPhenoDB Associates Metagenomic Data with Pathogenic Microbes, Microbial Core Genes, and Human Disease Phenotypes.
33419962 2021. Pathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples.
33420163 2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.
33422682 2021. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.
33423067 2021. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus.
33425046 2021. COV19-CNNet and COV19-ResNet: Diagnostic Inference Engines for Early Detection of COVID-19.
33425248 2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.
33426541 2020. Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19.
33426894 2021. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
33428900 2021. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.
33430309 2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
33431511 2021. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.
33434272 2021. Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.
33435561 2021. Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.
33437935 2021. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.
33440148 2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.
33441124 2021. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
33451855 2021. Dysregulation of Cell Signaling by SARS-CoV-2.
33453245 2021. The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
33454715 2021. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.
33456761 2020. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
33457042 2021. A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines.
33458462 2021. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.
33458747 2021. Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators.
33458761 2021. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
33464637 2021. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
33467724 2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.
33467896 2021. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.
33469197 2021. Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.
33469465 2020. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.
33469573 2021. COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone.
33469663 2021. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
33472860 2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.
33473155 2021. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.
33475497 2020. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
33478554 2021. Mechanistic modeling of the SARS-CoV-2 disease map.
33479166 2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
33479353 2021. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
33479725 2021. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.
33482326 2021. Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.
33482803 2021. A protocol for adding knowledge to Wikidata: aligning resources on human coronaviruses.
33485957 2021. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.
33491070 2021. Noncoding RNAs: modulators and modulatable players during infection-induced stress response.
33491459 2021. Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers.
33493287 2021. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
33495710 2020. A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets.
33499661 2021. RNA editors: key regulators of viral response in cancer patients.
33500591 2021. Probing CAS database as prospective antiviral agents against SARS-CoV-2 main protease.
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
33501381 2020. Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group.
33501435 2021. Severe COVID-19 associated variants linked to chemokine receptor gene control in monocytes and macrophages.
33501441 2021. Interferon-regulated genetic programs and JAK/STAT pathway activate the intronic promoter of the short ACE2 isoform in renal proximal tubules.
33502471 2021. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
33503446 2021. Multi-organ proteomic landscape of COVID-19 autopsies.
33504008 2021. Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach.
33504824 2021. Altered high-density lipoprotein composition and functions during severe COVID-19.
33505220 2021. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
33505977 2020. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.
33506945 2021. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
33508216 2021. Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
33510353 2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.
33510385 2021. The m(6)A methylome of SARS-CoV-2 in host cells.
33511102 2020. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.
33519902 2020. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.
33520118 2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.
33520952 2020. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
33521069 2020. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.
33521209 2022. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.
33521556 2020. Micronutrient deficiencies in patients with COVID-19: how metabolomics can contribute to their prevention and replenishment.
33521688 2021. COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders.
33521697 2021. A distinct innate immune signature marks progression from mild to severe COVID-19.
33521749 2021. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity.
33524041 2021. Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
33524124 2021. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
33526974 2021. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.
33530099 2021. Altered Blood Cell Traits Underlie a Major Genetic Locus of Severe COVID-19.
33530819 2021. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points.
33532126 2021. Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19.
33532779 2021. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
33532784 2021. SARS-CoV-2 recruits a haem metabolite to evade antibody immunity.
33533071 2021. Long non-coding RNAs: Promising new targets in pulmonary fibrosis.
33534793 2021. ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.
33535230 2021. jSRC: a flexible and accurate joint learning algorithm for clustering of single-cell RNA-sequencing data.
33536218 2021. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
33537060 2020. The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys.
33539484 2021. Three-dimensional chromatin in infectious disease-A role for gene regulation and pathogenicity?
33539530 2021. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
33539890 2021. FunCoup 5: Functional Association Networks in All Domains of Life, Supporting Directed Links and Tissue-Specificity.
33540583 2021. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
33540664 2021. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells.
33544720 2021. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
33547084 2021. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.
33555895 2021. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
33556147 2021. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.
33556247 2021. Transcriptional and Metabolic Control of Memory B Cells and Plasma Cells.
33558857 2021. Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19.
33564755 2021. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations.
33564793 2021. Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity.
33564978 2021. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
33564990 2021. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
33566951 2021. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
33569598 2021. Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment.
33571544 2021. Dissecting lipid metabolism alterations in SARS-CoV-2.
33574281 2021. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.
33576464 2021. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review).
33577681 2021. Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates.
33577760 2021. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
33578396 2021. Rapid detection of SARS-CoV-2 infection by multicapillary column coupled ion mobility spectrometry (MCC-IMS) of breath. A proof of concept study.
33580175 2021. Immunoreactive peptide maps of SARS-CoV-2.
33583045 2021. Network Meta-Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID-19 Pathologies.
33584997 2021. 3044 Cases reveal important prognosis signatures of COVID-19 patients.
33585567 2020. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells.
33585804 2021. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.
33586620 2021. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
33589624 2021. Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
33590968 2021. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
33594340 2021. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through analysis of Viral Genomics and Structure.
33594362 2021. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
33594364 2021. Bifurcated monocyte states are predictive of mortality in severe COVID-19.
33596252 2021. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
33596592 2021. Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.
33604698 2021. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
33606823 2021. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
33607766 2021. Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.
33610778 2021. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
33611340 2021. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
33612988 2021. Den molekularen Wirtszellveranderungen durch SARS-CoV-2 auf der Spur.
33613009 2021. Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication.
33615190 2021. SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options.
33615195 2021. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes.
33615696 2021. Application of spectral library prediction for parallel reaction monitoring of viral peptides.
33617253 2021. Applications of Protein Secondary Structure Algorithms in SARS-CoV-2 Research.
33618659 2021. Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.
33619245 2021. Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19.
33619478 2021. The Host Interactome of Spike Expands the Tropism of SARS-CoV-2.
33619490 2021. Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation.
33619493 2021. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
33620066 2021. Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.
33627767 2021. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
33629960 2021. Using Machine Learning to Collect and Facilitate Remote Access to Biomedical Databases: Development of the Biomedical Database Inventory.
33630927 2021. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
33631334 2021. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.
33631640 2021. Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling.
33635335 2021. A neutrophil activation signature predicts critical illness and mortality in COVID-19.
33635931 2021. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.
33636047 2021. An integrated genetic-epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID-19) and cancer.
33637823 2021. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
33639276 2021. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
33643762 2021. Cordifolioside: potent inhibitor against M(pro) of SARS-CoV-2 and immunomodulatory through human TGF-beta and TNF-alpha.
33645482 2021. Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19.
33647885 2021. The networks of m(6)A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis.
33648648 2021. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes.
33649539 2021. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.
33651717 2021. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.
33654293 2021. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
33655243 2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
33655247 2021. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.
33655248 2021. An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
33655257 2021. SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes.
33656857 2021. Rapid Detection of COVID-19 Using MALDI-TOF-Based Serum Peptidome Profiling.
33662365 2021. The serum metabolome of COVID-19 patients is distinctive and predictive.
33662681 2021. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
33663372 2021. OmicLoupe: facilitating biological discovery by interactive exploration of multiple omic datasets and statistical comparisons.
33664060 2021. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses.
33668405 2021. Comparative Transcriptome Profiling of Human and Pig Intestinal Epithelial Cells after Porcine Deltacoronavirus Infection.
33669808 2021. Ex uno, plures-From One Tissue to Many Cells: A Review of Single-Cell Transcriptomics in Cardiovascular Biology.
33670580 2021. MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.
33674719 2021. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection.
33677468 2021. Dynamic blood single-cell immune responses in patients with COVID-19.
33678150 2021. Integrated gut virome and bacteriome dynamics in COVID-19 patients.
33679760 2021. Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.
33679887 2021. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene.
33680474 2021. Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in silico analysis.
33683204 2021. SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung.
33683246 2021. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.
33683626 2021. Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19.
33684134 2021. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19.
33685230 2021. An immune epigenetic insight to COVID-19 infection.
33685349 2021. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
33688586 2021. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.
33688631 2020. Urine proteome of COVID-19 patients.
33688643 2021. Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals.
33691013 2021. Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome.
33691138 2021. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
33691144 2021. Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia.
33691172 2021. Contribution of STAT3 to the pathogenesis of COVID-19.
33691178 2021. First description of natural concomitant infection of avian nephritis virus and infectious bronchitis virus reveals exacerbated inflammatory response and renal damage in broiler chicks.
33691247 2021. Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution.
33693030 2021. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.
33693506 2021. COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases.
33704068 2021. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
33705542 2021. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
33707411 2021. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
33710662 2021. Evidence for CAT gene being functionally involved in the susceptibility of COVID-19.
33712587 2021. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
33712622 2021. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
33713114 2021. The Missing Expression Level-Evolutionary Rate Anticorrelation in Viruses Does Not Support Protein Function as a Main Constraint on Sequence Evolution.
33713597 2021. The SARS-CoV-2 subgenome landscape and its novel regulatory features.
33713619 2021. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
33716737 2021. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.
33717140 2021. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
33718452 2021. Single-Cell Transcriptome Analysis Decipher New Potential Regulation Mechanism of ACE2 and NPs Signaling Among Heart Failure Patients Infected With SARS-CoV-2.
33719350 2021. A Negative Feedback Model to Explain Regulation of SARS-CoV-2 Replication and Transcription.
33720333 2021. Comparison of In Situ Hybridization, Immunohistochemistry, and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Tissue.
33721144 2021. Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients.
33722935 2021. Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.
33723254 2021. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.
33724185 2021. Seroconversion stages COVID19 into distinct pathophysiological states.
33725751 2021. Circular RNA-MicroRNA-MRNA interaction predictions in SARS-CoV-2 infection.
33726831 2021. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
33727347 2021. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
33728103 2021. Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection.
33730015 2021. Gene variants of coagulation related proteins that interact with SARS-CoV-2.
33730572 2021. Translational adaptation of human viruses to the tissues they infect.
33732659 2021. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells.
33737124 2021. Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19.
33737684 2021. Proteomic blood profiling in mild, severe and critical COVID-19 patients.
33737694 2021. Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients.
33740387 2021. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
33743211 2021. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
33743212 2021. COVID-19 and the human innate immune system.
33744846 2021. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.
33749902 2021. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
33749993 2021. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis.
33751111 2021. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.
33751722 2021. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome.
33756482 2021. Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease.
33758849 2021. Comparative host interactomes of the SARS-CoV-2 nonstructural protein 3 and human coronavirus homologs.
33758858 2021. Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps.
33758859 2021. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19.
33758880 2021. High-resolution epigenome analysis in nasal samples derived from children with respiratory viral infections reveals striking changes upon SARS-CoV-2 infection.
33759345 2021. Risk stratification by long non-coding RNAs profiling in COVID-19 patients.
33762619 2021. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.
33762960 2021. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
33765435 2021. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses.
33765436 2021. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
33767597 2021. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19.
33767730 2021. Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients.
33769770 2021. Potential Endotype Transition for Coronavirus Disease 2019-Related Sepsis With Longitudinal Transcriptome Profiling.
33769912 2021. Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.
33772767 2021. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
33778090 2021. Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness.
33778306 2021. Proteomics Analysis of Serum from COVID-19 Patients.
33778787 2021. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
33780352 2021. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
33780434 2021. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
33780519 2021. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.
33785765 2021. SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.
33787872 2021. Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.
33791231 2021. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
33791703 2021. ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes.
33791717 2021. Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19.
33791720 2021. A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections.
33791731 2021. Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19.
33794925 2021. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
33796097 2021. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
33796130 2021. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection.
33801464 2021. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
33801496 2021. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery.
33806254 2021. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.
33807682 2021. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
33811809 2021. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
33812037 2021. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
33815307 2021. Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics.
33815688 2021. Nanopore sequencing and its application to the study of microbial communities.
33819681 2021. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.
33821222 2021. An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies.
33821252 2021. Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection.
33821262 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
33823303 2021. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
33823870 2021. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.
33828231 2021. From bedside to bench: regulation of host factors in SARS-CoV-2 infection.
33828579 2021. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.
33832440 2021. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.
33833618 2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
33833618 2021. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
33835998 2021. Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.
33836156 2021. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
33836368 2021. Identification of COVID-19 subtypes based on immunogenomic profiling.
33837377 2021. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
33837972 2021. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.
33838447 2021. Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells.
33839760 2021. Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19.
33841749 2021. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.
33845430 2021. The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.
33845483 2021. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
33846375 2021. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.
33846694 2021. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
33847185 2021. Therapeutic Nuclear Magnetic Resonance affects the core clock mechanism and associated Hypoxia-inducible factor-1.
33847347 2021. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
33848447 2021. Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung Injury.
33848683 2021. Systematizing the genomic order and relatedness in the open reading frames (ORFs) of the coronaviruses.
33849358 2021. An overview of proteomic methods for the study of 'cytokine storms'.
33851168 2021. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
33852178 2021. Efficient Human Cell Coexpression System and Its Application to the Production of Multiple Coronavirus Antigens.
33852884 2021. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.
33852916 2021. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
33855276 2021. Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy.
33855294 2021. Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case Report.
33860983 2021. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
33862077 2021. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2.
33864728 2021. Host PDZ-containing proteins targeted by SARS-CoV-2.
33867312 2021. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
33867313 2021. Epigenome-wide association study of COVID-19 severity with respiratory failure.
33868239 2021. Genetics Insight for COVID-19 Susceptibility and Severity: A Review.
33868293 2021. MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.
33868814 2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.
33868814 2021. Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome.
33872375 2021. A model of active transcription hubs that unifies the roles of active promoters and enhancers.
33876664 2021. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection.
33877681 2021. Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.
33879239 2021. IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.
33879756 2021. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.
33882487 2021. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.
33883027 2021. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
33883570 2021. Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells.
33883694 2021. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.
33883951 2021. Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis.
33884369 2021. Platypus: an open-access software for integrating lymphocyte single-cell immune repertoires with transcriptomes.
33884644 2021. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.
33887367 2021. Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data.
33888467 2021. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.
33888907 2021. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.
33891889 2021. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
33891947 2021. Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era.
33892139 2021. Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.
33892145 2021. Web resources facilitate drug discovery in treatment of COVID-19.
33893170 2021. Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.
33894177 2021. Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators.
33895135 2021. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.
33895478 2021. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.
33898797 2021. Identification of PBMC-based molecular signature associational with COVID-19 disease severity.
33898942 2021. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2.
33906069 2021. VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections.
33906662 2021. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
33907373 2021. Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity.
33907514 2021. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.
33907515 2021. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19.
33907518 2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
33907612 2021. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.
33907739 2021. Analysis workflow of publicly available RNA-sequencing datasets.
33907748 2021. Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export.
33907750 2022. Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo.
33907759 2021. Proteomic Profiling of MIS-C Patients Reveals Heterogeneity Relating to Interferon Gamma Dysregulation and Vascular Endothelial Dysfunction.
33907801 2021. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.
33913542 2021. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
33916492 2021. Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis.
33917481 2021. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
33918313 2021. A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework.
33919660 2021. Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics.
33919784 2021. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.
33923155 2021. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches.
33924082 2021. Presence of SARS-CoV-2 Nucleoprotein in Cardiac Tissues of Donors with Negative COVID-19 Molecular Tests.
33926500 2021. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.
33929923 2021. Can proteomics-based approaches further help COVID-19 prevention and therapy?
33930332 2021. Functional landscape of SARS-CoV-2 cellular restriction.
33932453 2021. Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations.
33935717 2021. Na(+)/K(+)-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection.
33936072 2021. Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.
33936086 2021. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia.
33937724 2021. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.
33940513 2021. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
33941085 2021. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
33941271 2021. Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study.
33941660 2021. Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
33942030 2021. Molecular Analysis of the Kidney From a Patient With COVID-19-Associated Collapsing Glomerulopathy.
33945677 2021. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
33946341 2021. Proteomics: A Tool to Study Platelet Function.
33946479 2021. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
33949668 2021. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.
33951416 2021. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection.
33953323 2021. Type I and III interferon responses in SARS-CoV-2 infection.
33956332 2021. Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins.
33956950 2021. The peripheral and core regions of virus-host network of COVID-19.
33958444 2021. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
33961822 2021. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection.
33961823 2021. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
33963053 2021. Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome.
33963054 2021. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
33963333 2021. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
33965637 2021. A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19.
33969282 2021. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.
33969287 2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
33969320 2021. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.
33969329 2021. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
33969601 2021. Interplay between SARS-CoV-2 and human long non-coding RNAs.
33972535 2021. Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features.
33972943 2021. Signaling through FcgammaRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.
33972946 2021. ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling.
33975939 2021. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.
33976430 2021. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
33979833 2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
33980279 2021. COVID19-CT-dataset: an open-access chest CT image repository of 1000+ patients with confirmed COVID-19 diagnosis.
33980308 2021. Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.
33981492 2021. Re-positive of SARS-CoV-2 test is common in COVID-19 patients after hospital discharge. Data from high standard post-discharge quarantined patients in Macao SAR, China.
33986193 2021. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
33987944 2021. Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
33991637 2021. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.
33992143 2021. Long-term effects of COVID-19 on kidney function.
33993053 2021. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19.
33993054 2021. An epigenetic signature to fight COVID-19.
33993223 2021. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
33994605 2021. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review.
33995033 2021. SARS-CoV-2 Switches 'on' MAPK and NFkappaB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.
33995382 2021. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.
33996501 2021. Design of advanced siRNA therapeutics for the treatment of COVID-19.
33996638 2021. The Unfolded Protein Response and Autophagy on the Crossroads of Coronaviruses Infections.
33997298 2021. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--.
34000623 2021. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.
34001664 2021. Detection of differentially abundant cell subpopulations in scRNA-seq data.
34002013 2021. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
34002169 2021. Sample processing and single cell RNA-sequencing of peripheral blood immune cells from COVID-19 patients.
34003736 2021. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
34004360 2021. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2.
34004362 2021. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.
34006825 2021. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.
34009992 2021. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome.
34010280 2021. The Biobanque quebecoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories.
34011150 2021. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis.
34013266 2020. Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways.
34013402 2021. Heterogeneity of SARS-CoV-2 virus produced in cell culture revealed by shotgun proteomics and supported by genome sequencing.
34014278 2021. 3DBionotes COVID-19 Edition.
34017039 2021. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.
34019265 2021. Molecular Mechanisms of Vascular Damage During Lung Injury.
34019643 2021. eVITTA: a web-based visualization and inference toolbox for transcriptome analysis.
34020131 2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.
34022127 2021. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
34022369 2021. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.
34023458 2021. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.
34027315 2021. Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci.
34027422 2021. Platelet and Haemostasis are the Main Targets in Severe Cases of COVID-19 Infection; a System Biology Study.
34027897 2021. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age.
34030677 2021. Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease.
34031243 2021. Transfer transcriptomic signatures for infectious diseases.
34031419 2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
34031419 2021. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
34031561 2021. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.
34031668 2021. Distinct Mucoinflammatory Phenotype and the Immunomodulatory Long Noncoding Transcripts Associated with SARS-CoV-2 Airway Infection.
34032635 2021. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.
34032881 2021. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome.
34034806 2021. Blood DNA methylation and COVID-19 outcomes.
34035220 2021. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
34036326 2021. A multi-modal data harmonisation approach for discovery of COVID-19 drug targets.
34045361 2021. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
34047474 2021. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.
34048708 2021. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
34048985 2021. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.
34051148 2021. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
34051791 2021. Dysregulation of COVID-19 related gene expression in the COPD lung.
34054532 2021. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.
34058265 2021. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
34058321 2021. Nrf2 activator PB125(R) as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19.
34061905 2021. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA.
34062119 2021. Integrated analysis of multimodal single-cell data.
34066850 2021. Human Gut Microbiome and Liver Diseases: From Correlation to Causation.
34068142 2021. Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.
34069591 2021. Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection.
34070662 2021. Breast Milk and COVID-19: From Conventional Data to "Omics" Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers.
34073047 2021. Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes.
34073578 2021. Ceramide and Related Molecules in Viral Infections.
34075347 2021. SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.
34075354 2021. A matter of perspective-Cutting-edge technology-driven urine proteome in COVID-19.
34075365 2021. Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19.
34075374 2021. SARS-CoV-2 Nsp14 activates NF-kappaB signaling and induces IL-8 upregulation.
34075380 2021. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence.
34078893 2021. A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.
34083512 2021. Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers.
34086487 2021. Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection.
34089082 2021. SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies.
34089367 2021. Transcriptome analysis of primary chicken cells infected with infectious bronchitis virus strain K047-12 isolated in Korea.
34090218 2021. COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.
34092811 2021. mRNA Targeting, Transport and Local Translation in Eukaryotic Cells: From the Classical View to a Diversity of New Concepts.
34093642 2021. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data.
34094635 2021. Construction of a Human Cell Landscape of COVID-19 Infection at Single-cell Level.
34094684 2021. Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.
34098591 2021. An Impaired Inflammatory and Innate Immune Response in COVID-19.
34099652 2021. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.
34100020 2021. Signatures of mast cell activation are associated with severe COVID-19.
34100027 2021. Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation.
34100031 2021. IL10RB as a key regulator of COVID-19 host susceptibility and severity.
34101213 2021. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.
34103487 2021. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.
34104087 2021. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.
34105201 2021. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
34106748 2021. N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Delta4-Desaturase 1-Independent Mechanism.
34107055 2021. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
34108016 2021. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.
34108465 2021. Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection.
34108657 2021. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
34108966 2021. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19.
34109017 2021. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.
34110264 2021. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
34112226 2021. Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients.
34112877 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
34116667 2021. A blood RNA transcriptome signature for COVID-19.
34117734 2021. DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19.
34117968 2022. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.
34118117 2021. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
34121407 2021. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
34122515 2021. Transcriptional Start Site Coverage Analysis in Plasma Cell-Free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients.
34127431 2021. AI-guided discovery of the invariant host response to viral pandemics.
34127534 2021. Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.
34127837 2021. How COVID-19 disrupts glycometabolic control.
34127963 2021. Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics.
34127967 2021. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells.
34127970 2021. Identification of ACE2 modifiers by CRISPR screening.
34128959 2021. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
34128960 2021. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
34131597 2021. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling.
34132373 2021. SARSCoV2 spike proteininduced host inflammatory response signature in human corneal epithelial cells.
34133077 2021. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.
34135895 2021. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
34137202 2021. Optimization of a modeling platform to predict oncogenes from genome-scale metabolic networks of non-small-cell lung cancers.
34139154 2021. A time-resolved proteomic and prognostic map of COVID-19.
34139362 2021. Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients.
34140500 2021. Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection.
34143756 2021. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.
34146538 2021. Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A24:02 and homologous to a SARS-CoV-2 peptide.
34146958 2021. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione.
34147651 2021. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
34150352 2021. Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.
34151035 2021. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19.
34153974 2021. Dysregulation of brain and choroid plexus cell types in severe COVID-19.
34155207 2021. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
34155406 2021. SARS-CoV-2-specific hotspots in virus-host interaction networks.
34155559 2021. Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.
34156871 2021. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Kappa18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
34157472 2021. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
34157486 2021. 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study.
34157565 2021. Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
34158670 2021. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.
34159360 2021. Precision omics data integration and analysis with interoperable ontologies and their application for COVID-19 research.
34159380 2021. Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins.
34159627 2021. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
34160250 2021. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
34160596 2021. LSTM-PHV: prediction of human-virus protein-protein interactions by LSTM with word2vec.
34163359 2021. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.
34163728 2021. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
34165401 2022. Interfering with the Reactive Cysteine Proteome in COVID-19.
34168039 2021. Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.
34168100 2021. Triglyceride regulate ACE2 level through MTHFD1.
34168400 2021. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.
34177037 2021. Convolutional neural network for diagnosis of viral pneumonia and COVID-19 alike diseases.
34179538 2021. Computational search of hybrid human/SARS-CoV-2 dsRNA reveals unique viral sequences that diverge from those of other coronavirus strains.
34179732 2021. Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.
34180141 2021. Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.
34180678 2021. Genetic Variability of the SARS-CoV-2 Pocketome.
34181887 2021. Nuclear factor-kappa B and its role in inflammatory lung disease.
34183789 2021. An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.
34185889 2021. An epigenome-wide DNA methylation study of patients with COVID-19.
34186206 2021. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection.
34186245 2021. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.
34188786 2021. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
34189529 2021. Predicting gene regulatory networks from multi-omics to link genetic risk variants and neuroimmunology to Alzheimer's disease phenotypes.
34193364 2022. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
34195193 2021. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.
34196300 2021. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.
34197816 2021. From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic.
34200325 2021. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.
34200959 2021. Discovery of Antivirals Using Phage Display.
34202032 2021. Direct Measurement of B Lymphocyte Gene Expression Biomarkers in Peripheral Blood Transcriptomics Enables Early Prediction of Vaccine Seroconversion.
34202098 2021. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
34204705 2021. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.
34205098 2021. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
34205975 2021. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.
34219142 2021. Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.
34220199 2021. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.
34222663 2021. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Plasmodium malariae share sequence homology.
34224783 2021. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).
34225477 2021. Implication of epitranscriptomics in trained innate immunity and COVID-19.
34225491 2021. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
34225749 2021. HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.
34226277 2021. A serum proteome signature to predict mortality in severe COVID-19 patients.
34226622 2021. Understanding protection from SARS-CoV-2 using metabolomics.
34226623 2021. UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.
34228902 2021. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
34228987 2021. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
34232536 2021. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
34232570 2021. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.
34234324 2021. Single-cell transcriptomics reveals neuroinflammation in severe COVID-19.
34235261 2021. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.
34237472 2021. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.
34240574 2021. Multiplexing Methods for Simultaneous Large-Scale Transcriptomic Profiling of Samples at Single-Cell Resolution.
34242574 2021. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.
34245241 2021. Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals.
34246161 2021. High-throughput analysis of the interactions between viral proteins and host cell RNAs.
34248311 2021. Genetic Control of Human Infection with SARS-CoV-2.
34248840 2021. Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.
34248940 2021. Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.
34250515 2021. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
34251833 2021. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts.
34252234 2022. Long noncoding RNAs in respiratory viruses: A review.
34252574 2021. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.
34253708 2021. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.
34254909 2021. COVID-19 candidate genes and pathways potentially share the association with lung cancer.
34254996 2021. ADEIP: an integrated platform of age-dependent expression and immune profiles across human tissues.
34256840 2021. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.
34257311 2021. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
34258664 2021. Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
34260159 2021. Individual COVID-19 disease trajectories revealed by plasma proteomics.
34260266 2021. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
34260684 2021. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.
34262555 2021. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
34272374 2021. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.
34272434 2021. Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis.
34274470 2021. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19.
34274504 2021. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.
34274539 2021. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19.
34276672 2021. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
34278363 2021. Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action.
34281603 2021. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.
34281608 2021. SARS-CoV-2: from its discovery to genome structure, transcription, and replication.
34282210 2021. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.
34282405 2021. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
34282425 2021. Plasma P-selectin is an early marker of thromboembolism in COVID-19.
34287999 2022. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors.
34289024 2021. SPOT: a web-tool enabling swift profiling of transcriptomes.
34289534 2021. High-resolution HLA genotyping identifies alleles associated with severe COVID-19: A preliminary study from India.
34289974 2022. Metabolomic analyses reveal new stage-specific features of COVID-19.
34290742 2021. Identification of Causal Genes of COVID-19 Using the SMR Method.
34291285 2021. Biochemical composition, transmission and diagnosis of SARS-CoV-2.
34292740 2021. DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
34294141 2021. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.
34297037 2021. Epigenetic and transcriptional control of interferon-beta.
34297909 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34301919 2021. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
34305429 2021. Relevance between COVID-19 and host genetics of immune response.
34306168 2021. Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.
34307679 2021. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.
34307909 2021. Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma.
34308298 2021. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome.
34308390 2021. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
34308480 2021. scAdapt: virtual adversarial domain adaptation network for single cell RNA-seq data classification across platforms and species.
34308962 2021. Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption.
34311260 2021. Transcription factor NF-kappaB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.
34312624 2021. SARS-CoV-2 Restructures the Host Chromatin Architecture.
34313294 2021. A lipidomic view of SARS-CoV-2.
34315173 2021. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.
34315200 2021. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review.
34315815 2021. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.
34315903 2021. Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization.
34320031 2021. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
34320442 2021. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.
34321474 2021. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
34322127 2021. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
34325286 2021. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
34326461 2021. FIP200 restricts RNA virus infection by facilitating RIG-I activation.
34326952 2021. Immunometabolic bases of type 2 diabetes in the severity of COVID-19.
34329437 2021. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.
34330463 2021. The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19.
34330510 2021. Gene signatures of autopsy lungs from obese patients with COVID-19.
34330886 2021. A 34-Year-Old Woman from Brazil with Pulmonary Lymphangioleiomyomatosis Diagnosed by Raised Serum Vascular Endothelial Growth Factor-D (VEGF-D) Levels and Lung Cysts on Computed Tomography Imaging Presenting with COVID-19 Pneumonia.
34330889 2021. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
34331874 2021. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease.
34332518 2021. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
34333072 2021. Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach.
34333764 2022. Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.
34335580 2021. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
34335605 2021. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
34335977 2021. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.
34336867 2021. Genome Editing Technologies as Cellular Defense Against Viral Pathogens.
34337272 2021. Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery.
34339582 2021. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
34341659 2021. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
34341788 2021. Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine.
34341789 2021. Molecular Pathophysiology of Cardiac Injury and Cardiac Microthrombi in Fatal COVID-19: Insights from Clinico-histopathologic and Single Nuclei RNA Sequencing Analyses.
34345808 2021. JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules.
34348612 2021. Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes.
34359932 2021. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
34359957 2021. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women.
34360732 2021. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.
34360778 2021. Detecting and Profiling Endogenous RNA G-Quadruplexes in the Human Transcriptome.
34360824 2021. SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis.
34361874 2021. SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells.
34366686 2021. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson's disorder.
34367154 2021. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
34367190 2021. Monocytes and Macrophages in COVID-19.
34367265 2021. Metabolomics in the Diagnosis and Prognosis of COVID-19.
34368185 2021. Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.
34373319 2021. Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of three proteins from SARS-CoV-2.
34373855 2021. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.
34375459 2021. A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E.
34376481 2021. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
34377996 2021. COVID-19-associated inhibition of energy accumulation pathways in human semen samples.
34379666 2021. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
34381049 2021. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children.
34383213 2021. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.
34383242 2021. Genomic evolution of the human and animal coronavirus diseases.
34384361 2021. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants.
34385425 2021. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
34387838 2022. Overview of SARS-CoV-2 genome-encoded proteins.
34390301 2022. Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
34392148 2021. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.
34394094 2021. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.
34394108 2021. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
34394120 2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.
34401873 2021. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release.
34402426 2021. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
34402498 2022. Infection outcome needs two to tango: human host and the pathogen.
34404832 2021. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal.
34405154 2021. Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins.
34406356 2021. coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.
34407143 2021. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L.
34407940 2021. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity.
34408743 2021. Fast and Efficient Genome Editing of Human FOXP3(+) Regulatory T Cells.
34408749 2021. Long Noncoding RNAs as Emerging Regulators of COVID-19.
34409594 2021. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production.
34413339 2021. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs.
34414385 2021. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis.
34416267 2021. Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells.
34419773 2021. Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
34423353 2021. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
34424199 2021. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
34425843 2021. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
34430958 2021. Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance.
34432798 2021. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals.
34433692 2021. Profound Treg perturbations correlate with COVID-19 severity.
34433821 2021. Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions.
34433827 2021. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.
34433832 2021. Homology between SARS CoV-2 and human proteins.
34436507 2021. Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans.
34437303 2021. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children.
34437657 2021. SARS-CoV-2 suppresses IFNbeta production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
34440372 2021. Methylation of Host Genes Associated with Coronavirus Infection from Birth to 26 Years.
34440669 2021. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients.
34440765 2021. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
34441862 2021. Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection.
34445741 2021. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites.
34446707 2021. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
34447375 2021. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
34448730 2021. A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity.
34451848 2021. Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease.
34452305 2021. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
34452405 2021. Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease.
34452458 2021. Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19.
34452933 2021. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
34452991 2021. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
34458641 2021. Host gene variability and SARS-CoV-2 infection: A review article.
34458692 2021. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19.
34460840 2021. Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
34462737 2021. An antigen microarray protocol for COVID-19 serological analysis.
34462739 2021. Upper airway gene expression reveals a more robust innate and adaptive immune response to SARS-CoV-2 in children compared with older adults.
34462747 2021. Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner.
34465742 2021. Genome-wide association study of COVID-19 severity among the Chinese population.
34465887 2021. Trans-ethnic genome-wide association study of severe COVID-19.
34468193 2021. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights.
34471255 2021. Cellular host factors for SARS-CoV-2 infection.
34473805 2021. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
34476621 2021. Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study.
34477316 2021. SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: An in-silico proof-of-principle of proteomics-based drug repurposing.
34478921 2021. Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients.
34482267 2021. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways.
34488908 2021. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
34489933 2021. Cytokine Signature Associated With Disease Severity in COVID-19.
34492226 2021. The interferon landscape along the respiratory tract impacts the severity of COVID-19.
34494892 2022. Implications of the NADase CD38 in COVID pathophysiology.
34496960 2021. Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets.
34497809 2021. Transcriptomic Signatures of Airway Epithelium Infected With SARS-CoV-2: A Balance Between Anti-infection and Virus Load.
34502105 2021. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).
34502134 2021. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
34502454 2021. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism.
34504087 2021. Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation.
34504487 2021. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
34504502 2021. The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis.
34505137 2022. Serverless computing in omics data analysis and integration.
34506304 2021. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.
34506752 2021. Molecular Profiling of Coronavirus Disease 2019 (COVID-19) Autopsies Uncovers Novel Disease Mechanisms.
34508917 2021. Autoimmunity roots of the thrombotic events after COVID-19 vaccination.
34511738 2021. CovH2SD: A COVID-19 detection approach based on Harris Hawks Optimization and stacked deep learning.
34511970 2021. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients.
34512253 2021. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome.
34512723 2021. ACE2 Netlas: In silico Functional Characterization and Drug-Gene Interactions of ACE2 Gene Network to Understand Its Potential Involvement in COVID-19 Susceptibility.
34513131 2021. Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review.
34516880 2021. Platelets amplify endotheliopathy in COVID-19.
34517025 2021. Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation.
34517257 2021. Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-kappaB pathway.
34518653 2022. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis.
34519533 2021. Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.
34522117 2021. Plasma Metabolomic Profiles in Recovered COVID-19 Patients without Previous Underlying Diseases 3 Months After Discharge.
34523966 2021. The NF-kappaB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.
34524690 2022. Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
34531370 2021. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients.
34531741 2021. Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics.
34531865 2021. Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome.
34534839 2021. Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
34534994 2021. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children.
34535662 2021. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses.
34535740 2021. Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target.
34535791 2021. Structural biology of SARS-CoV-2 and implications for therapeutic development.
34535795 2022. Network-based analysis revealed significant interactions between risk genes of severe COVID-19 and host genes interacted with SARS-CoV-2 proteins.
34536277 2021. Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
34538015 2021. Platelets contribute to disease severity in COVID-19.
34538334 2021. Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients.
34539756 2021. Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome.
34541422 2021. Nicotinamide Adenine Dinucleotide Biosynthetic Impairment and Urinary Metabolomic Alterations Observed in Hospitalized Adults With COVID-19-Related Acute Kidney Injury.
34541878 2021. Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.
34542605 2021. Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability.
34545347 2021. The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
34545375 2021. Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19.
34545716 2021. Potential of application of the RNA interference phenomenon in the treatment of new coronavirus infection COVID-19.
34548480 2021. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
34552685 2021. Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19.
34556735 2021. Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates.
34558746 2021. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis.
34560321 2021. Gut Microbiome Alterations in COVID-19.
34562452 2021. An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15.
34562466 2022. Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
34562480 2022. Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution.
34565757 2021. AI for the collective analysis of a massive number of genome sequences: various examples from the small genome of pandemic SARS-CoV-2 to the human genome.
34566957 2021. Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.
34566994 2021. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
34567001 2021. Persistent High Percentage of HLA-DR(+)CD38(high) CD8(+) T Cells Associated With Immune Disorder and Disease Severity of COVID-19.
34569339 2021. A scoping review of the pathophysiology of COVID-19.
34571150 2022. Transcriptome analysis of host response to porcine epidemic diarrhea virus nsp15 in IPEC-J2 cells.
34571838 2021. Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection.
34571855 2021. Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
34572076 2021. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
34572329 2021. Epigenetic Mechanisms Underlying COVID-19 Pathogenesis.
34576716 2021. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection.
34578187 2021. Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.
34578338 2021. Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells.
34580297 2021. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2.
34580601 2021. Network Pharmacology Reveals That Resveratrol Can Alleviate COVID-19-Related Hyperinflammation.
34580671 2021. A BioID-derived proximity interactome for SARS-CoV-2 proteins.
34581622 2021. A prenylated dsRNA sensor protects against severe COVID-19.
34582564 2022. Adipose tissue and blood leukocytes ACE2 DNA methylation in obesity and after weight loss.
34584097 2021. In vivo structure and dynamics of the SARS-CoV-2 RNA genome.
34586723 2021. Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients.
34587478 2021. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes.
34592166 2021. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
34594031 2021. Systematic investigation of cytokine signaling activity at the tissue and single-cell levels.
34594344 2021. Combined Transcriptome and Proteome Leukocyte's Profiling Reveals Up-Regulated Module of Genes/Proteins Related to Low Density Neutrophils and Impaired Transcription and Translation Processes in Clinical Sepsis.
34597346 2021. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
34598020 2021. Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses.
34601331 2021. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.
34601771 2022. PDB-101: Educational resources supporting molecular explorations through biology and medicine.
34603282 2021. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers.
34603366 2021. Graph Representation Forecasting of Patient's Medical Conditions: Toward a Digital Twin.
34603483 2021. Identification of Novel COVID-19 Biomarkers by Multiple Feature Selection Strategies.
34604700 2021. Association of Asthma and Rhinitis with Epigenetics of Coronavirus Related Genes.
34604720 2021. The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium.
34608452 2021. Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19.
34612687 2021. PABPC4 Broadly Inhibits Coronavirus Replication by Degrading Nucleocapsid Protein through Selective Autophagy.
34612698 2021. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients.
34615934 2021. Drug repositioning by merging active subnetworks validated in cancer and COVID-19.
34615949 2021. Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients.
34616396 2021. SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril).
34619366 2021. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication.
34620315 2021. mNUTRIC tool is capable to predict nutritional needs and mortality early in patients suffering from severe pneumonia.
34624207 2021. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.
34624208 2021. Role of miR-2392 in driving SARS-CoV-2 infection.
34630400 2021. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach.
34630427 2021. Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study.
34630432 2021. Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report.
34630433 2021. Diversity of Macrophages in Lung Homeostasis and Diseases.
34632957 2021. Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota.
34633277 2022. Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19.
34638691 2021. The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure.
34638812 2021. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
34642692 2021. Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients.
34642700 2021. Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae.
34643448 2021. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
34644561 2021. Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
34647998 2022. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.
34650546 2021. ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1.
34653729 2021. In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR.
34655901 2021. Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities.
34659188 2021. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition.
34659213 2021. Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP-1): A Key Player of Host Defense and Immune Regulation.
34659373 2021. Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.
34660538 2021. Machine Learning of Serum Metabolic Patterns Encodes Asymptomatic SARS-CoV-2 Infection.
34661254 2021. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
34662402 2022. Detection of Neanderthal Adaptively Introgressed Genetic Variants That Modulate Reporter Gene Expression in Human Immune Cells.
34663977 2021. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.
34669152 2022. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
34670213 2022. The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent.
34671206 2021. The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly.
34671355 2021. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
34672376 2022. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
34672606 2021. Advances and Utility of the Human Plasma Proteome.
34672947 2021. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome.
34672954 2022. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.
34675048 2022. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
34675242 2021. Meta-analysis of COVID-19 single-cell studies confirms eight key immune responses.
34675292 2021. Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress.
34675930 2021. Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection.
34676128 2020. Plasma metabolomic and lipidomic alterations associated with COVID-19.
34677374 2021. SARS-CoV2 Infection Alters Tryptophan Catabolism and Phospholipid Metabolism.
34677415 2021. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.
34678084 2021. Top Trends in Multiomics Research: Evaluation of 52 Published Studies and New Ways of Thinking Terminology and Visual Displays.
34681641 2021. G-Quadruplex Targeting in the Fight against Viruses: An Update.
34681944 2021. Alveolar Regeneration in COVID-19 Patients: A Network Perspective.
34686343 2021. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome.
34686777 2021. Accurate detection and quantification of SARS-CoV-2 genomic and subgenomic mRNAs by ddPCR and meta-transcriptomics analysis.
34687295 2021. Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA.
34687317 2021. Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling.
34691068 2021. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.
34694399 2021. ADAR Editing in Viruses: An Evolutionary Force to Reckon with.
34695380 2021. Folding Intermediates, Heterogeneous Native Ensembles and Protein Function.
34696164 2021. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.
34696353 2021. SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives.
34697287 2021. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.
34698500 2022. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.
34698547 2021. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.
34702802 2021. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication.
34708437 2022. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics.
34709564 2022. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.
34709707 2021. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
34709727 2021. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
34710339 2022. Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19.
34715493 2021. Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K/Akt pathway.
34715923 2021. Dysregulation of RNA interference components in COVID-19 patients.
34716309 2021. Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.
34722002 2021. HLA alleles measured from COVID-19 patient transcriptomes reveal associations with disease prognosis in a New York cohort.
34722003 2021. Effect of SARS-CoV-2 infection on host competing endogenous RNA and miRNA network.
34722158 2022. MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19.
34722346 2021. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach.
34723157 2021. Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19.
34723226 2021. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2.
34725650 2021. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives.
34729561 2021. An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19.
34730223 2021. Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA.
34730254 2021. Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation.
34731091 2021. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
34731648 2021. An airway organoid-based screen identifies a role for the HIF1alpha-glycolysis axis in SARS-CoV-2 infection.
34732330 2022. Nrf2/Keap1/ARE signaling: Towards specific regulation.
34732709 2021. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.
34734602 2021. Harnessing stress granule formation by small molecules to inhibit the cellular replication of SARS-CoV-2.
34735713 2022. Metabolomics Signatures of SARS-CoV-2 Infection.
34737357 2022. Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.
34740309 2021. Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection.
34741638 2022. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations.
34745097 2021. The Omic Insights on Unfolding Saga of COVID-19.
34746476 2021. Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs.
34746710 2021. Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium.
34746856 2021. Computational workflow for functional characterization of COVID-19 through secondary data analysis.
34748989 2021. COVID-ONE-hi: The One-stop Database for COVID-19-specific Humoral Immunity and Clinical Parameters.
34750486 2021. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
34750520 2022. Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation.
34755842 2022. Association of cardiometabolic microRNAs with COVID-19 severity and mortality.
34756970 2021. SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review.
34757528 2021. Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection.
34757848 2022. A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.
34758415 2021. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
34758478 2022. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
34762662 2021. Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens.
34762851 2021. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
34764623 2022. Decision and feature level fusion of deep features extracted from public COVID-19 data-sets.
34771023 2021. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.
34773448 2021. C-reactive protein as an effector molecule in Covid-19 pathogenesis.
34774005 2021. Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study.
34774773 2021. Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses.
34774827 2022. Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis.
34775353 2021. Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.
34775559 2022. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma.
34775962 2021. Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19.
34776871 2021. PTSD as an Endothelial Disease: Insights From COVID-19.
34777349 2021. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
34777369 2021. Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19.
34777716 2021. Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon.
34778851 2022. Machine learning and network medicine approaches for drug repositioning for COVID-19.
34781739 2021. A Bacterial Cell-Based Assay To Study SARS-CoV-2 Protein-Protein Interactions.
34781747 2021. A Previously Undiscovered Circular RNA, circTNFAIP3, and Its Role in Coronavirus Replication.
34781986 2021. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.
34782627 2021. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
34782790 2022. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
34786180 2021. On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein.
34786539 2021. Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors.
34786557 2020. Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems.
34787756 2022. Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis.
34788642 2022. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
34788843 2022. The reactome pathway knowledgebase 2022.
34790191 2021. COVID-19 Mechanisms in the Human Body-What We Know So Far.
34790908 2021. Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples.
34791032 2022. Detection of COVID-19 by Machine Learning Using Routine Laboratory Tests.
34795232 2021. Jumper enables discontinuous transcript assembly in coronaviruses.
34799561 2021. Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities.
34801852 2022. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
34802985 2021. HDL proteome remodeling associates with COVID-19 severity.
34804904 2021. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
34807957 2021. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.
34812416 2021. Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis.
34812694 2021. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.
34815890 2021. Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response.
34819170 2021. Epigenetic modifications in thymic epithelial cells: an evolutionary perspective for thymus atrophy.
34819389 2022. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
34822387 2021. Single-Cell Multiomics Analysis for Drug Discovery.
34824452 2022. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design.
34826456 2022. Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome.
34830872 2021. Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients.
34831176 2021. Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication.
34831243 2021. Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes.
34831290 2021. Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections.
34831321 2021. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity.
34832622 2021. Single-Cell Genomics: Enabling the Functional Elucidation of Infectious Diseases in Multi-Cell Genomes.
34834944 2021. Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2.
34835019 2021. Single-Cell RNAseq Profiling of Human gammadelta T Lymphocytes in Virus-Related Cancers and COVID-19 Disease.
34835064 2021. CRISPR Screening: Molecular Tools for Studying Virus-Host Interactions.
34837225 2022. COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
34837942 2021. A multitask transfer learning framework for the prediction of virus-human protein-protein interactions.
34841243 2021. Genetic epidemiology using whole genome sequencing and haplotype networks revealed the linkage of SARS-CoV-2 infection in nosocomial outbreak.
34841355 2021. A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia.
34844191 2021. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms.
34844647 2021. treekoR: identifying cellular-to-phenotype associations by elucidating hierarchical relationships in high-dimensional cytometry data.
34845370 2022. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
34845387 2021. A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations.
34845442 2021. Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction.
34845443 2021. Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing.
34845446 2021. Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19.
34845452 2021. Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets.
34845457 2021. Severe COVID-19 induces molecular signatures of aging in the human brain.
34845458 2021. An immune correlate of SARS-CoV-2 infection and severity of reinfections.
34848322 2022. Understanding the role of telomere attrition and epigenetic signatures in COVID-19 severity.
34849574 2022. SC-MEB: spatial clustering with hidden Markov random field using empirical Bayes.
34850892 2021. Gene Expression Risk Scores for COVID-19 Illness Severity.
34851327 2021. Case Report: First Confirmed Case of Coinfection of SARS-CoV-2 With Choclo orthohantavirus.
34851990 2021. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
34857794 2021. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease.
34858473 2021. Identification of Intercellular Signaling Changes Across Conditions and Their Influence on Intracellular Signaling Response From Multiple Single-Cell Datasets.
34859078 2021. Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin alphaIIbbeta3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.
34859136 2021. A Nucleocapsid-based Transcomplementation Cell Culture System of SARS-CoV-2 to Recapitulate the Complete Viral Life Cycle.
34863291 2021. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality.
34864875 2022. Multiomics integration-based molecular characterizations of COVID-19.
34867933 2021. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities.
34867988 2021. Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests.
34869070 2021. Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS.
34870243 2022. Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis.
34873589 2021. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden.
34875673 2022. Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection.
34877479 2022. Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication.
34877545 2022. Global metabolome profiling of COVID-19 respiratory specimen using high-resolution mass spectrometry (HRMS).
34878333 2021. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
34878902 2022. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
34880855 2021. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
34882757 2021. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
34884813 2021. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases.
34887515 2021. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets.
34889978 2022. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
34893580 2021. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
34893640 2021. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction.
34895312 2021. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
34898980 2021. Evolutionary Dynamics of Indels in SARS-CoV-2 Spike Glycoprotein.
34899557 2021. A Combined Clinical and Serum Biomarker-Based Approach May Allow Early Differentiation Between Patients With Minor Stroke and Transient Ischemic Attack as Well as Mid-term Prognostication.
34899651 2021. Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
34899680 2021. Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs.
34899693 2021. Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.
34901782 2022. SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.
34901888 2022. Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing.
34902130 2022. Scenarios for the Integration of Microarray Gene Expression Profiles in COVID-19-Related Studies.
34903581 2021. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes.
34905515 2022. Clinico-histopathologic and single-nuclei RNA-sequencing insights into cardiac injury and microthrombi in critical COVID-19.
34906319 2021. Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches.
34908151 2022. Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p.
34912867 2021. Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation.
34914162 2022. A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
34914922 2021. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
34914966 2022. Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection.
34915155 2022. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.
34915500 2022. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
34916489 2021. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors.
34917069 2021. The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis.
34917088 2021. m(6)A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients.
34917662 2021. Detailed Analyses of the Expression Patterns of Potential Severe Acute Respiratory Syndrome Coronavirus 2 Receptors in the Human Heart Using Single-Nucleus RNA Sequencing.
34919255 2021. SARS-CoV-2 associated pathogenesis, immune dysfunction and involvement of host factors: a comprehensive review.
34920753 2021. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
34921044 2021. Commentary: Morphoproteomics and Data Mining of the Medical Literature Define the Pathobiology of COVID-19 Pneumonitis in Humans and Provide Adjuvant Therapeutic Options.
34922446 2021. GraphOmics: an interactive platform to explore and integrate multi-omics data.
34925252 2021. Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients.
34926320 2021. Pathogen-Host Interaction Repertoire at Proteome and Posttranslational Modification Levels During Fungal Infections.
34928464 2021. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
34931002 2022. Single-cell immunology of SARS-CoV-2 infection.
34931188 2021. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-beta signaling.
34937774 2022. sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
34938288 2021. Aging-Related Impairments to M Cells in Peyer's Patches Coincide With Disturbances to Paneth Cells.
34938772 2021. Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients.
34940501 2021. Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome.
34940588 2021. Plasma Lipidomic and Metabolomic Profiling after Birth in Neonates Born to SARS-CoV-19 Infected and Non-Infected Mothers at Delivery: Preliminary Results.
34940605 2021. Metabolomics Diagnosis of COVID-19 from Exhaled Breath Condensate.
34940755 2021. Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis.
34942634 2022. Evolution of enhanced innate immune evasion by SARS-CoV-2.
34943719 2021. A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug.
34943787 2021. SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.
34944005 2021. Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19.
34944012 2021. Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization.
34946083 2021. Structure-Function Characteristics of SARS-CoV-2 Proteases and Their Potential Inhibitors from Microbial Sources.
34947989 2021. MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease.
34950134 2021. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.
34950146 2021. IL1beta Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis.
34950606 2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.
34951103 2022. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19.
34954105 2022. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
34956212 2021. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
34956213 2021. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome.
34959132 2022. Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms.
34960054 2021. Dracocephalum moldavica Ethanol Extract Suppresses LPS-Induced Inflammatory Responses through Inhibition of the JNK/ERK/NF-kappaB Signaling Pathway and IL-6 Production in RAW 264.7 Macrophages and in Endotoxic-Treated Mice.
34960648 2021. JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
34960687 2021. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.
34960725 2021. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
34960752 2021. Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis.
34960772 2021. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.
34960822 2021. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
34963103 2021. Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases.
34965194 2022. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
34966385 2021. Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19.
34967936 2021. Embeddings from protein language models predict conservation and variant effects.
34969849 2022. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.
34975885 2021. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
34981034 2022. Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19.
34982558 2022. Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV.
34990653 2022. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.
34993416 2021. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications.
34995097 2022. Innate immunological pathways in COVID-19 pathogenesis.
34998467 2022. SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.
35002688 2021. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19.
35003084 2021. SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene.
35005527 2022. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics.
35005991 2022. Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges.
35008724 2021. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
35011584 2021. Role of Human Antigen R (HuR) in the Regulation of Pulmonary ACE2 Expression.
35011641 2021. The Genomic Physics of COVID-19 Pathogenesis and Spread.
35013560 2022. Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population.
35017320 2022. Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration.
35017628 2022. InterCellar enables interactive analysis and exploration of cell-cell communication in single-cell transcriptomic data.
35018096 2022. Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis.
35021853 2022. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks.
35022217 2022. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
35022412 2022. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation.
35022513 2022. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-kappaB.
35022857 2022. Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19.
35026155 2022. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.
35027067 2022. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
35028855 2022. Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients.
35032429 2022. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
35032732 2022. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia.
35033679 2022. Genomic perspectives on the emerging SARS-CoV-2 omicron variant.
35036860 2022. Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19.
35037717 2022. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients.
35037854 2022. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
35039944 2022. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.
35043114 2022. A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections.
35043127 2022. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
35045126 2022. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
35045565 2022. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
35047828 2020. Mini review: Recent progress in RT-LAMP enabled COVID-19 detection.
35052382 2021. Detection of A-to-I RNA Editing in SARS-COV-2.
35052628 2022. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome.
35053299 2022. Hypoxia-Inducible Factor Signaling in Inflammatory Lung Injury and Repair.
35056076 2021. Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.
35059135 2021. Syncytin, envelope protein of human endogenous retrovirus (HERV): no longer 'fossil' in human genome.
35060145 2022. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
35060381 2022. Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
35063125 2022. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
35064006 2022. Plasma cell-free RNA characteristics in COVID-19 patients.
35064122 2022. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19.
35067165 2022. SARS-CoV-2 targets the lysosome to mediate airway inflammatory cell death.
35069552 2021. Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis.
35072167 2021. Host methylation predicts SARS-CoV-2 infection and clinical outcome.
35073995 2022. IDEAS: individual level differential expression analysis for single-cell RNA-seq data.
35074468 2022. Betacoronavirus-specific alternate splicing.
35075101 2022. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
35079083 2022. Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression.
35079870 2022. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives.
35081105 2022. RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections.
35082790 2021. The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis.
35083167 2021. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3.
35085240 2022. Impact of high platelet turnover on the platelet transcriptome: Results from platelet RNA-sequencing in patients with sepsis.
35085577 2022. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
35090661 2022. Mass spectrometry applied to diagnosis, prognosis, and therapeutic targets identification for the novel coronavirus SARS-CoV-2: A review.
35091528 2022. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients.
35091530 2022. Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques.
35091696 2022. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes.
35091890 2022. Antibody glycosylation in COVID-19.
35091986 2022. The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing.
35093087 2022. Dynamic regulation and functions of mRNA m6A modification.
35095375 2021. NF-KB A KEY TRANSCRIPTION FACTOR IN DISEASE PROGRESSION OF PATIENTS WITH COVID-19.
35095855 2021. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.
35095875 2021. Monolaurin Confers a Protective Effect Against Porcine Epidemic Diarrhea Virus Infection in Piglets by Regulating the Interferon Pathway.
35095877 2021. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
35095900 2021. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.
35100036 2022. Specific Regulatory Motifs Network in SARS-CoV-2-Infected Caco-2 Cell Line, as a Model of Gastrointestinal Infections.
35100869 2022. Gasdermin D Inhibits Coronavirus Infection by Promoting the Noncanonical Secretion of Beta Interferon.
35102215 2022. Metabolomics study of COVID-19 patients in four different clinical stages.
35106136 2021. Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients.
35107034 2022. Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner.
35108055 2022. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion.
35110370 2022. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
35110370 2022. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
35111156 2021. Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response.
35113990 2022. Silent Hypoxia in COVID-19 Pneumonia: State of Knowledge, Pathophysiology, Mechanisms, and Management.
35114443 2022. Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids.
35115549 2022. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.
35118467 2022. Variant to function mapping at single-cell resolution through network propagation.
35118477 2022. T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.
35123426 2022. Possible kidney-lung cross-talk in COVID-19: in silico modeling of SARS-CoV-2 infection.
35124429 2022. SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network.
35126380 2021. Swine Enteric Coronaviruses (PEDV, TGEV, and PDCoV) Induce Divergent Interferon-Stimulated Gene Responses and Antigen Presentation in Porcine Intestinal Enteroids.
35126398 2022. Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease.
35127841 2021. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection.
35128085 2022. Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data.
35128501 2022. Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19.
35131599 2022. Association of gut-related metabolites with respiratory symptoms in COVID-19: A proof-of-concept study.
35131898 2022. Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
35132419 2022. Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries.
35132424 2022. Blood transcriptomes of SARS-CoV-2 infected kidney transplant recipients demonstrate immune insufficiency.
35133633 2022. Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning.
35133846 2022. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
35133977 2022. Single-cell RNA sequencing reveals induction of distinct trained-immunity programs in human monocytes.
35133988 2022. T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.
35136165 2022. An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking.
35136970 2022. Increased brain volume from higher cereal and lower coffee intake: shared genetic determinants and impacts on cognition and metabolism.
35139355 2022. Interferon-gamma primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway.
35139909 2022. Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis.
35141213 2021. A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2-Related Genes in Kidney Renal Clear Cell Carcinoma.
35141230 2021. Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis.
35141569 2022. Transcriptome profiling of PBMCs and formalin-fixed autopsy tissues from COVID-19 patients.
35143212 2022. Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19.
35143839 2022. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin alpha5beta1 and NF-kappaB signaling.
35145507 2021. Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies.
35148199 2022. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.
35148261 2022. Mixed-weight Neural Bagging for Detecting m6A Modifications in SARS-CoV-2 RNA Sequencing.
35151371 2022. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease.
35153822 2021. The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
35154070 2021. T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients.
35154090 2022. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
35157021 2022. Multi-Level Attention Graph Neural Network Based on Co-expression Gene Modules for Disease Diagnosis and Prognosis.
35159296 2022. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
35163833 2022. AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome.
35164139 2022. A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine.
35164548 2022. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
35169146 2022. Cell specific peripheral immune responses predict survival in critical COVID-19 patients.
35169794 2022. Comparative analysis of cell-cell communication at single-cell resolution.
35171039 2022. Endothelial inflammation and dysfunction in COVID-19.
35172892 2022. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
35173714 2022. All-Trans Retinoic Acid Attenuates Transmissible Gastroenteritis Virus-Induced Inflammation in IPEC-J2 Cells via Suppressing the RLRs/NF-kappaB Signaling Pathway.
35173764 2021. KeyPathwayMineR: De Novo Pathway Enrichment in the R Ecosystem.
35177862 2022. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.
35178029 2021. Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets.
35179038 2022. Phenome-Wide Association Study of Severe COVID-19 Genetic Risk Variants.
35180397 2022. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4.
35180460 2022. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients.
35181735 2022. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
35185603 2021. COVID-19 and Mitochondrial Non-Coding RNAs: New Insights From Published Data.
35185890 2022. Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis.
35186014 2021. Single-Cell Differential Network Analysis with Sparse Bayesian Factor Models.
35186784 2021. Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naive and Recovered Individuals Vaccinated With Inactivated Vaccine.
35186917 2022. Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations.
35189575 2022. The impact of hypoxia on B cells in COVID-19.
35192147 2022. PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19.
35194198 2022. Next generation self-replicating RNA vectors for vaccines and immunotherapies.
35194601 2022. The mechanism of RNA capping by SARS-CoV-2.
35194610 2022. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
35196007 2022. Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery.
35202626 2022. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity.
35203278 2022. The ACE2 Receptor for Coronavirus Entry Is Localized at Apical Cell-Cell Junctions of Epithelial Cells.
35204689 2022. Looking at COVID-19 from a Systems Biology Perspective.
35205046 2022. Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity.
35205390 2022. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2.
35205926 2022. Molecular Profiling Reveals Characteristic and Decisive Signatures in Patients after Allogeneic Stem Cell Transplantation Suffering from Invasive Pulmonary Aspergillosis.
35208734 2022. Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2.
35211117 2022. Are There Hidden Genes in DNA/RNA Vaccines?
35212764 2022. Proteomic Profiling Identifies Novel Proteins for Genetic Risk of Severe COVID-19: the Atherosclerosis Risk in Communities Study.
35215915 2022. Secondary Structure of Subgenomic RNA M of SARS-CoV-2.
35215921 2022. Carbohydrate Ligands for COVID-19 Spike Proteins.
35215969 2022. Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
35216673 2022. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
35217532 2022. Specialized interferon action in COVID-19.
35221000 2021. Viral Genome Integration into the Host Cell Genome: A Double Edged-Sword.
35222346 2022. The Hidden Enemy Within: Non-canonical Peptides in Virus-Induced Autoimmunity.
35223838 2022. Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.
35224468 2022. Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses.
35226074 2022. CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
35226991 2022. Thymosin-alpha1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia.
35229015 2022. Blood metabolites predicting mild cognitive impairment in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL).
35229157 2022. Unheeded SARS-CoV-2 proteins? A deep look into negative-sense RNA.
35232816 2022. The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression.
35233542 2022. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples.
35233546 2022. System-wide transcriptome damage and tissue identity loss in COVID-19 patients.
35233559 2021. Defense of COVID-19 by Human Organoids.
35233572 2022. Targeted Down Regulation Of Core Mitochondrial Genes During SARS-CoV-2 Infection.
35233578 2022. Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions.
35234938 2022. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution.
35235083 2022. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
35237749 2022. A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases.
35239653 2022. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.
35242109 2022. Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.
35244721 2022. Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs.
35248659 2022. Role of genomics in combating COVID-19 pandemic.
35251015 2022. SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics.
35251616 2022. A novel concept of human antiviral protection: It's all about RNA (Review).
35252121 2022. Editorial: Protein Glycosylation-Advances in Identification, Characterization and Biological Function Elucidation Using Mass Spectrometry.
35255492 2022. Whole-genome sequencing reveals host factors underlying critical COVID-19.
35258762 2022. Integrated analysis of gut microbiome and host immune responses in COVID-19.
35261621 2022. Post-treatment with propofol inhibits inflammatory response in LPS-induced alveolar type II epithelial cells.
35265835 2022. Feature selection for kernel methods in systems biology.
35269470 2022. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.
35272104 2022. Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood.
35277538 2022. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
35281785 2022. SARS-CoV-2 triggered oxidative stress and abnormal energy metabolism in gut microbiota.
35282650 2022. The Key Genes Underlying Pathophysiology Correlation Between the Acute Myocardial Infarction and COVID-19.
35284643 2022. An experimental in silico study on COVID-19: Response of neutrophil-related genes to antibiotics.
35284913 2022. Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients.
35288537 2022. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge.
35288942 2022. When cyclin-dependent kinases meet viral infections, including SARS-CoV-2.
35290573 2022. A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options.
35293857 2022. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
35294846 2022. Detection techniques for epitranscriptomic marks.
35296346 2022. Autoimmunity is a hallmark of post-COVID syndrome.
35301508 2022. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells.
35301621 2022. Comparative trachea transcriptome analysis in SPF broiler chickens infected with avian infectious bronchitis and avian influenza viruses.
35301654 2022. Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results.
35303126 2022. Identification of G-quadruplex DNA sequences in SARS-CoV2.
35305698 2022. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
35309096 2021. Multi-Omics-Guided Discovery of Omicsynins Produced by Streptomyces sp. 1647: Pseudo-Tetrapeptides Active Against Influenza A Viruses and Coronavirus HCoV-229E.
35309299 2022. Signaling Through FcgammaRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
35309488 2022. Semen Proteomics of COVID-19 Convalescent Men Reveals Disruption of Key Biological Pathways Relevant to Male Reproductive Function.
35310032 2022. Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice.
35310073 2022. SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling.
35311586 2022. Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens.
35311624 2022. DNA methylation profiles in pneumonia patients reflect changes in cell types and pneumonia severity.
35313583 2022. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation.
35313584 2022. Genetic control of the dynamic transcriptional response to immune stimuli and glucocorticoids at single cell resolution.
35313658 2022. The accessible promoter-mediated supplementary effect of host factors provides new insight into the tropism of SARS-CoV-2.
35314694 2022. Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest.
35317263 2022. Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19.
35318325 2022. Integrative transcriptomic, evolutionary, and causal inference framework for region-level analysis: Application to COVID-19.
35318674 2022. SARS-CoV-2, SARS-CoV, and MERS-CoV encode circular RNAs of spliceosome-independent origin.
35319744 2022. Late Complications of COVID-19: A Morphologic, Imaging, and Droplet Digital Polymerase Chain Reaction Study of Lung Tissue.
35320721 2022. Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.
35320939 2022. Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation-Early Secretomes may Serve as Drivers for Trained Immunity.
35322240 2022. Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses.
35326463 2022. Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription.
35328087 2022. Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients.
35328409 2022. SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights.
35331159 2022. Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker.
35332098 2022. Global mapping of RNA homodimers in living cells.
35336922 2022. Multiorgan and Vascular Tropism of SARS-CoV-2.
35336960 2022. Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19.
35337019 2022. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.
35339845 2022. Integration of omics data to generate and analyse COVID-19 specific genome-scale metabolic models.
35340030 2022. Mast cells in lung damage of COVID-19 autopsies: A descriptive study.
35342878 2022. Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication.
35343064 2022. RNA-protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV-2 studies.
35343384 2022. Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV.
35350199 2022. Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.
35350779 2022. Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution.
35351411 2022. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.
35354968 2022. SARS-CoV-2 pathogenesis.
35363626 2022. Patterns of Inflammatory Cell Infiltration and Expression of STAT6 in the Lungs of Patients With COVID-19: An Autopsy Study.
35364615 2022. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.
35369457 2022. Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients.
35371005 2022. Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza.
35372520 2022. Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites.
35373054 2021. COVID-19-associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron.
35373282 2022. Vive la Resistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection.
35379171 2022. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.
35379747 2022. Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
35380990 2022. Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19.
35381016 2022. Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.
35386719 2022. Causal Association and Shared Genetics Between Asthma and COVID-19.
35391730 2022. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin.
35392323 2022. SARS-CoV-2 Interaction with Human DNA Methyl Transferase 1: A Potential Risk for Increasing the Incidence of Later Chronic Diseases in the Survived Patients.
35393464 2022. Host-pathogen dynamics in longitudinal clinical specimens from patients with COVID-19.
35394619 2022. Single-Cell Transcriptome Analysis Reveals the Role of Pancreatic Secretome in COVID-19 Associated Multi-organ Dysfunctions.
35395058 2022. Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
35397534 2022. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.
35399374 2022. Unique peptide signatures of SARS-ComicronV-2 virus against human proteome reveal variants' immune escape and infectiveness.
35401515 2022. Differential Transcriptomics Analysis of IPEC-J2 Cells Single or Coinfected With Porcine Epidemic Diarrhea Virus and Transmissible Gastroenteritis Virus.
35401544 2022. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
35401574 2022. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
35402570 2022. In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19.
35405523 2022. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.
35406806 2022. Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response.
35410379 2022. Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects.
35410380 2022. Understanding COVID-19 through genome-wide association studies.
35412852 2022. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response.
35416291 2022. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
35416308 2022. A pyrosequencing protocol for rapid identification of SARS-CoV-2 variants.
35419822 2022. Anti-IFN-alpha/-omega neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.
35421082 2022. Abnormal global alternative RNA splicing in COVID-19 patients.
35421120 2022. Dysregulation of the leukocyte signaling landscape during acute COVID-19.
35421970 2022. Co-expression analysis to identify key modules and hub genes associated with COVID-19 in platelets.
35422810 2022. Alterations of Urinary Microbial Metabolites and Immune Indexes Linked With COVID-19 Infection and Prognosis.
35422859 2022. Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19.
35427985 2022. Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction.
35429230 2022. Viral and cellular translation during SARS-CoV-2 infection.
35430876 2022. Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.
35434485 2022. Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes.
35434695 2022. Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis.
35434729 2022. A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2.
35436306 2022. An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.
35438176 2022. Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality.
35441166 2022. Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19.
35445579 2022. Recent insights into the structure and function of coronavirus ribonucleases.
35446921 2022. Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.
35450534 2022. Epigenetic-related effects of COVID-19 on the human cells.
35451177 2022. Photocatalytic Chemical Crosslinking for Profiling RNA-Protein Interactions in Living Cells.
35453568 2022. Molecular Mechanism of Pancreatic beta-Cell Failure in Type 2 Diabetes Mellitus.
35458690 2022. The Dysregulation of the Renin-Angiotensin System in COVID-19 Studied by Serum Proteomics: Angiotensinogen Increases with Disease Severity.
35459226 2022. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology.
35459913 2022. Novel potential metabolic biomarker panel for early detection of severe COVID-19 using full-spectrum metabolome and whole-transcriptome analyses.
35460571 2022. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.
35461273 2022. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
35461900 2022. Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2.
35464324 2022. MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features.
35464396 2022. Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.
35464423 2022. Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis.
35464437 2022. Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection.
35464969 2022. Rapid and Accurate Detection of SARS Coronavirus 2 by Nanopore Amplicon Sequencing.
35465056 2022. BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant.
35469237 2022. Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19).
35469796 2022. Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
35470238 2022. Subgenomic RNA profiling suggests novel mechanism in coronavirus gene regulation and host adaption.
35474745 2022. Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.
35474751 2022. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
35476817 2022. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
35477000 2022. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
35477940 2022. Integrated analysis of transcriptomic data reveals the platelet response in COVID-19 disease.
35479098 2022. Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.
35480316 2022. Global Gene Expression and Docking Profiling of COVID-19 Infection.
35480886 2022. Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naive Subjects.
35482476 2022. Dysregulated Ligand-receptor interactions from single cell transcriptomics.
35482673 2022. A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program.
35490333 2022. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine.
35493473 2022. Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray.
35496775 2022. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination.
35501398 2022. Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways.
35501841 2022. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19.
35502318 2022. Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.
35502829 2022. Bees can be trained to identify SARS-CoV-2 infected samples.
35506060 2022. Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.
35508791 2022. Identification of serum metabolites enhancing inflammatory responses in COVID-19.
35511057 2022. deepHPI: a comprehensive deep learning platform for accurate prediction and visualization of host-pathogen protein-protein interactions.
35514065 2022. Phase Separation: "The Master Key" to Deciphering the Physiological and Pathological Functions of Cells.
35520289 2022. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19.
35525888 2022. Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19.
35528173 2022. Discovering Common Pathophysiological Processes between COVID-19 and Cystic Fibrosis by Differential Gene Expression Pattern Analysis.
35528178 2022. Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods.
35529862 2022. Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.
35531330 2022. Possible Mechanism of SARS-CoV-2 Nsp1-Mediated Control of Viral Gene Expression.
35532162 2022. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
35533462 2022. Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.
35533463 2022. Enrichment analysis on regulatory subspaces: A novel direction for the superior description of cellular responses to SARS-CoV-2.
35534210 2022. Endothelialitis, Microischemia, and Intussusceptive Angiogenesis in COVID-19.
35536669 2022. A phase I trial of cyclosporine for hospitalized patients with COVID-19.
35538614 2022. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease.
35538880 2022. Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS.
35543509 2022. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
35543533 2022. Impaired exercise capacity in post-COVID syndrome: the role of VWF-ADAMTS13 axis.
35547851 2022. CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates.
35554907 2022. Profiling SARS-CoV-2 Infection by High-Throughput Shotgun Proteomics.
35554915 2022. Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.
35558576 2022. Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.
35563697 2022. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
35568706 2022. Sex differences in global metabolomic profiles of COVID-19 patients.
35572561 2022. Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19.
35572676 2022. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
35573725 2022. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19.
35574937 2022. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
35577777 2022. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.
35577935 2022. A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection.
35581179 2022. Proteomic characterization of Omicron SARS-CoV-2 host response.
35582459 2022. Analyzing single cell transcriptome data from severe COVID-19 patients.
35582503 2022. Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection.
35583305 2022. Retinal Findings of Hospitalized Neonates Recovered from COVID-19 Infection: A Prospective, Observational, Descriptive Study.
35584589 2022. Roles of PIKfyve in multiple cellular pathways.
35586248 2022. Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19.
35593050 2022. ScoMorphoFISH: A deep learning enabled toolbox for single-cell single-mRNA quantification and correlative (ultra-)morphometry.
35598057 2022. Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.
35598647 2022. TRPC6 is altered in COVID-19 pneumonia.
35599705 2022. Molecular analysis of vascular gene expression.
35602196 2021. Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection.
35604092 2022. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.
35604092 2022. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.
35605482 2022. Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome.
35610660 2022. Transcriptomic perspectives of memory-like NK cells and aging.
35611119 2022. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2.
35618891 2022. Host genetic basis of COVID-19: from methodologies to genes.
35620480 2022. Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods.
35622336 2022. Single-Cell Analysis and Tracking of Antigen-Specific T Cells: Integrating Paired Chain AIRR-Seq and Transcriptome Sequencing: A Method by the AIRR Community.
35625619 2022. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing.
35631558 2022. A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis.
35632654 2022. Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.
35632738 2022. High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients.
35632741 2022. SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions.
35632779 2022. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.
35634344 2022. The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses.
35634577 2022. Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection.
35639648 2022. Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study.
35639883 2022. Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers.
35639922 2022. A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients.
35640981 2022. DeepLUCIA: predicting tissue-specific chromatin loops using Deep Learning-based Universal Chromatin Interaction Annotator.
35645252 2022. Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19.
35648852 2022. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19.
35654986 2022. The impact of the suppression of highly connected protein interactions on the corona virus infection.
35655464 2022. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients.
35657140 2022. Screening the hub genes and analyzing the mechanisms in discharged COVID-19 patients retesting positive through bioinformatics analysis.
35661108 2022. RNA editing detection in SARS-CoV-2 transcriptome should be different from traditional SNV identification.
35661455 2022. Deregulation of ceRNA Networks in Frontal Cortex and Choroid Plexus of Brain during SARS-CoV-2 Infection Aggravates Neurological Manifestations: An Insight from Bulk and Single-Cell Transcriptomic Analyses.
35662463 2022. PEPPI: Whole-proteome Protein-protein Interaction Prediction through Structure and Sequence Similarity, Functional Association, and Machine Learning.
35663631 2022. Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19: A Step Toward Targeted Therapies.
35663953 2022. N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients.
35664076 2022. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
35664804 2022. The Ramp Atlas: facilitating tissue and cell-specific ramp sequence analyses through an intuitive web interface.
35664994 2022. Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases.
35669390 2022. Identification of novel regulatory pathways across normal human bronchial epithelial cell lines (NHBEs) and peripheral blood mononuclear cell lines (PBMCs) in COVID-19 patients using transcriptome analysis.

Full dataset second search term

these were retrieved by the filtered second omics search and seem to be important
33915460 2021. Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32818817 2020. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.
32916377 2020. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
34883069 2022. SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged due to glycan interaction.
33631204 2021. Ca(2+)-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide.
33607086 2021. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
33484712 2021. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein.
33460600 2021. Improving SARS-CoV-2 structures: Peer review by early coordinate release.
34087218 2021. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2.
33675757 2021. Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane.
33359834 2021. The Molecular Mechanism of Domain Swapping of the C-Terminal Domain of the SARS-Coronavirus Main Protease.
35378756 2022. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
35043110 2022. Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery.
34127974 2022. Multi-color super-resolution imaging to study human coronavirus RNA during cellular infection.
35132414 2022. SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer's-like neuropathology.
34189530 2021. Super.Complex: A supervised machine learning pipeline for molecular complex detection in protein-interaction networks.
34873599 2021. A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular features.
33758856 2021. Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.
34159327 2021. Double-stranded RNA drives SARS-CoV-2 nucleocapsid protein to undergo phase separation at specific temperatures.
33501444 2021. An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
33442700 2021. Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2.
33299996 2021. Ca (2+) -dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide.
33564772 2021. Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography.
33083801 2021. Reconstructed signaling and regulatory networks identify potential drugs for SARS-CoV-2 infection.
32995791 2020. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection.
33083802 2020. Progressive and accurate assembly of multi-domain protein structures from cryo-EM density maps.
32511343 2020. Controlling the SARS-CoV-2 Spike Glycoprotein Conformation.
32511405 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32511375 2020. A single-cell RNA expression map of human coronavirus entry factors.
32577653 2020. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins.
32766587 2020. The SARS-CoV-2 Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.
32766577 2020. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors.
32511311 2020. Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses.
32587966 2020. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.
32817938 2020. An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.
32677879 2020. Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm.
33504336 2021. Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures.
34535131 2021. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
33892639 2021. Online biophysical predictions for SARS-CoV-2 proteins.
32611313 2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
35241064 2022. Alterations in the oral microbiome of individuals with a healthy oral environment following COVID-19 vaccination.
34674775 2021. Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19.
34308111 2021. No evidence that vitamin D is able to prevent or affect the severity of COVID-19 in individuals with European ancestry: a Mendelian randomisation study of open data.
35322889 2022. Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials.
32745239 2020. Abnormal concentration of porphyrins in serum from COVID-19 patients.
34632567 2022. Pyroptosis targeting via mitochondria: An educated guess to innovate COVID-19 therapies.
34962256 2022. Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation.
34058750 2021. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.
33757279 2021. Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2.
32924062 2021. Origin-independent analysis links SARS-CoV-2 local genomes with COVID-19 incidence and mortality.
32917504 2021. Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.
33203441 2020. Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
34019795 2021. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
34010620 2021. High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
33831372 2021. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
33974910 2021. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
32353252 2020. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
32155444 2020. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
33792836 2021. Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex.
32992409 2021. SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.
35139898 2022. Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients.
33510134 2021. N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2.
33850112 2021. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages.
33298875 2020. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility.
33915112 2021. Detect and destroy: CRISPR-based technologies for the response against viruses.
34081913 2021. SARS-CoV-2 infection induces beta cell transdifferentiation.
34921308 2022. A humanized mouse model of chronic COVID-19.
34489601 2022. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19.
33829608 2021. Adenosine triphosphate energy-independently controls protein homeostasis with unique structure and diverse mechanisms.
34396938 2021. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
34520596 2022. Biochemical strategies of E3 ubiquitin ligases target viruses in critical diseases.
32922564 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32828084 2020. Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states.
35132731 2022. Histidine-enhanced gene delivery systems: The state of the art.
34788130 2021. The Impact of IFNlambda4 on the Adaptive Immune Response to SARS-CoV-2 Infection.
35148193 2022. Exploring the Link Between Vitamin D Deficiency and Cytokine Storms in COVID-19 Patients: An In Silico Analysis.
32964419 2021. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
35451490 2022. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
35032087 2022. Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID-19 vaccine.
35404084 2022. Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
35554920 2022. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
34914045 2022. Artificial Intelligence in Vaccine and Drug Design.
34914044 2022. mRNA Vaccines to Protect Against Diseases.
34766264 2022. High-Dimensional Immunophenotyping with 37-Color Panel Using Full-Spectrum Cytometry.
34731469 2022. Network-Driven Drug Discovery.
34014525 2021. Viral PDZ Binding Motifs Influence Cell Behavior Through the Interaction with Cellular Proteins Containing PDZ Domains.
34813758 2022. Deubiquitinases: From mechanisms to their inhibition by small molecules.
34592048 2022. From cells to atoms: Cryo-EM as an essential tool to investigate pathogen biology, host-pathogen interaction, and drug discovery.
34675424 2022. Single-cell profiling of proteins and chromatin accessibility using PHAGE-ATAC.
33536629 2021. Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents.
33723418 2021. Lessons learned: new insights on the role of cytokines in COVID-19.
33184509 2021. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells.
32807934 2020. A dynamic COVID-19 immune signature includes associations with poor prognosis.
35236990 2022. The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes.
35536253 2022. BioUML-towards a universal research platform.
33688867 2021. 1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication.
34008647 2021. Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2.
32812956 2020. Dynamical properties of enzyme-substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
33295347 2020. Tracing the driving forces responsible for the remarkable infectivity of 2019-nCoV: 1. Receptor binding domain in its bound and unbound states.
34506164 2021. Dynamics-Evolution Correspondence in Protein Structures.
32996197 2021. Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.
35119706 2022. Structure and dynamics of the SARS-CoV-2 envelope protein monomer.
34936112 2022. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
34914544 2022. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
33446556 2021. Learning the language of viral evolution and escape.
34168070 2021. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
33408195 2021. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
34388849 2021. Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination.
34529510 2021. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
33462384 2021. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors.
33637958 2021. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
32047258 2020. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.
35536484 2022. Intracellular mono-ADP-ribosyltransferases at the host-virus interphase.
35013790 2022. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
35141964 2022. Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health.
35477024 2022. Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry.
35235831 2022. BCG vaccination provides protection against IAV but not SARS-CoV-2.
35172173 2022. Cryo-EM structure of the SARS-CoV-2 Omicron spike.
35421379 2022. Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection.
34592170 2021. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition.
34739850 2021. Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection.
34004174 2021. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.
34166618 2021. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.
33778788 2021. A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses.
33377122 2020. Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons.
35128513 2022. Multi-color super-resolution imaging to study human coronavirus RNA during cellular infection.
34465913 2021. Mechanical activation of spike fosters SARS-CoV-2 viral infection.
33737693 2021. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.
33742149 2021. SARS-CoV-2 spike protein interacts with and activates TLR41.
35032430 2022. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids.
32725381 2020. Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain.
34685626 2021. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A02:01 Recognised by a Public TCR.
34685765 2021. Shedding Light on the Possible Link between ADAMTS13 and Vaccine-Induced Thrombotic Thrombocytopenia.
34831382 2021. Identification of Cellular Factors Required for SARS-CoV-2 Replication.
34440659 2021. The Immune System Throws Its Traps: Cells and Their Extracellular Traps in Disease and Protection.
34571891 2021. CytokineLink: A Cytokine Communication Map to Analyse Immune Responses-Case Studies in Inflammatory Bowel Disease and COVID-19.
33918600 2021. Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.
33238570 2020. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.
32443810 2020. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.
32545714 2020. Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.
34047452 2021. SARS-CoV-2 first contact: Spike-ACE2 interactions in COVID-19.
34265150 2021. Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.
32986926 2021. Binding of SARS-CoV-2 to Cell Receptors: A Tale of Molecular Evolution.
32663362 2020. ACE2, the Receptor that Enables Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
33217417 2021. Lower Respiratory Tract Myeloid Cells Harbor SARS-Cov-2 and Display an Inflammatory Phenotype.
32004165 2020. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.
33405941 2021. Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells.
35283094 2022. Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients.
35600135 2022. Inflammatory reflex disruption in COVID-19.
32568187 2020. COVID-19 and the endothelium.
32390611 2020. How we should respond to the Coronavirus SARS-CoV-2 outbreak: A German perspective.
32497191 2020. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.
33285276 2021. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity.
33511992 2021. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
35573165 2022. Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
34484739 2021. Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohorts.
33209300 2020. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.
32864128 2020. Systematic analysis of disease-specific immunological signatures in patients with febrile illness from Saudi Arabia.
35590097 2022. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
35194132 2022. A synthetic protein as efficient multitarget regulator against complement over-activation.
35478219 2022. A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition.
34853399 2021. Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
33875803 2021. Amplification-free RNA detection with CRISPR-Cas13.
35339763 2022. Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
35569336 2022. Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods.
32658736 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
34695114 2021. Multicellular spatial model of RNA virus replication and interferon responses reveals factors controlling plaque growth dynamics.
34793437 2021. Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections.
34310589 2021. Covasim: An agent-based model of COVID-19 dynamics and interventions.
33793546 2021. Computational epitope map of SARS-CoV-2 spike protein.
35353808 2022. RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells.
35390060 2022. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
35275926 2022. Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes.
34972161 2021. Super.Complex: A supervised machine learning pipeline for molecular complex detection in protein-interaction networks.
33730017 2021. Structural analysis of viral ExoN domains reveals polyphyletic hijacking events.
33481950 2021. Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice.
32330208 2020. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study.
33493182 2021. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
33886690 2021. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
32150576 2020. Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry.
35321887 2022. High level of lactate dehydrogenase and ischaemia-reperfusion injury regulate the multiple organ dysfunction in patients with COVID-19.
35576468 2022. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
35165203 2022. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
35022216 2022. Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes.
35363556 2022. Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle.
34548411 2021. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
34782481 2021. Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein.
33906951 2021. Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
34903654 2021. An open repository of real-time COVID-19 indicators.
34873039 2021. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells.
32994342 2020. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.
32376634 2020. Cell entry mechanisms of SARS-CoV-2.
32503918 2020. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.
32606248 2020. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface.
32654247 2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.
35043109 2022. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
32702726 2020. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation.
33031639 2021. What every researcher should know about searching - clarified concepts, search advice, and an agenda to improve finding in academia.
33083782 2020. Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity.
34338380 2022. Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020?
35424441 2021. Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19.
34623907 2021. Transient lipid-bound states of spike protein heptad repeats provide insights into SARS-CoV-2 membrane fusion.
34757794 2021. A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections.
33277323 2021. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.
33536217 2021. Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19.
32948512 2020. Antibody-like proteins that capture and neutralize SARS-CoV-2.
34413140 2021. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
34413139 2021. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
34593915 2021. COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19.
34620887 2021. A smart mask for active defense against airborne pathogens.
34675240 2021. Cytokine signature and COVID-19 prediction models in the two waves of pandemics.
34741071 2021. Diosmectite inhibits the interaction between SARS-CoV-2 and human enterocytes by trapping viral particles, thereby preventing NF-kappaB activation and CXCL10 secretion.
34737330 2021. Link between serum lipid signature and prognostic factors in COVID-19 patients.
34290262 2021. Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry.
33608565 2021. Flexibility and mobility of SARS-CoV-2-related protein structures.
33436498 2021. Cytoplasmic short linear motifs in ACE2 and integrin beta3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy.
33436497 2021. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.
35258337 2022. KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.
34648371 2021. Replication and single-cycle delivery of SARS-CoV-2 replicons.
34016740 2021. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.
33685461 2021. Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation.
34534731 2021. Structure of SARS-CoV-2 spike protein.
33884756 2021. Single-cell systems biology, COVID-19, and vaccination.
33291622 2020. Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic.
32657473 2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
33609782 2021. Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
33971404 2021. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.
35600330 2022. Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19.
35323112 2022. The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein.
35323111 2022. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike.
35294338 2022. Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry.
33443016 2021. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.
33570492 2021. The allosteric modulation of complement C5 by knob domain peptides.
34930527 2021. 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography.
34350827 2021. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.
33899740 2021. High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing.
32452762 2020. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
32559343 2020. Rationale for targeting complement in COVID-19.
35527514 2022. ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion.
34989664 2022. Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.
33258732 2020. Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens.
32178593 2020. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.
33235976 2020. Combating COVID-19 with tissue engineering: a review.
35221835 2022. Environmental factors influencing the transmission of the coronavirus 2019: a review.
33223326 2021. Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach.
32846644 2020. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.
32959998 2020. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature.
35151223 2022. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy.
33812315 2021. Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists.
32919938 2020. Macrophage responses associated with COVID-19: A pharmacological perspective.
32444400 2020. COVID-19 and the nicotinic cholinergic system.
32269085 2020. Pathogenesis of COVID-19 from a cell biology perspective.
34112047 2022. Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy.
34654347 2021. Cross-talk between immune system and microbiota in COVID-19.
35157347 2022. Structural polymorphism of coiled-coils from the stalk domain of SARS-CoV-2 spike protein.
33368679 2021. Spatial and temporal roles of SARS-CoV PL(pro) -A snapshot.
32562316 2020. A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.
33449359 2021. Dynamics and electrostatics define an allosteric druggable site within the receptor-binding domain of SARS-CoV-2 spike protein.
32449939 2020. SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection.
32379896 2020. Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs.
32374074 2020. Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease.
33503469 2021. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.
33838172 2021. Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via alpha7-nicotinic acetylcholine receptors?
33640537 2021. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.
33038452 2020. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
33855053 2021. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.
33604359 2021. Microvascular Angiopathic Consequences of COVID-19.
35517495 2022. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes.
35141167 2021. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome.
34869058 2021. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
32850499 2020. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
33304243 2020. Neuropathobiology of COVID-19: The Role for Glia.
33681145 2021. Viroporins vs. Other Pore-Forming Proteins: What Lessons Can We Take?
35573805 2022. Open data facilitate resilience in science during the COVID-19 pandemic.
34925459 2021. Approaching Genetics Through the MHC Lens: Tools and Methods for HLA Research.
34603376 2021. A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients.
35663932 2022. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
35572555 2022. Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2.
35386702 2022. Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.
35359960 2022. On the Origin of Neutrophil Extracellular Traps in COVID-19.
35350780 2022. How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment.
35058926 2021. Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response.
34603283 2021. Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.
34484241 2021. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain.
34093595 2021. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
33912161 2021. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.
33692801 2021. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
33643285 2020. VISTA: A Target to Manage the Innate Cytokine Storm.
33584719 2020. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
34805220 2021. Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19.
34095160 2021. iOntoBioethics: A Framework for the Agile Development of Bioethics Ontologies in Pandemics, Applied to COVID-19.
35444632 2022. Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders.
35283834 2022. Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins.
34707577 2021. Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota.
33815346 2021. Learning From Mistakes: The Role of Phages in Pandemics.
33101264 2020. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2.
33042039 2020. Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution.
35087864 2021. CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2.
35004841 2021. Energy Bilocalization Effect and the Emergence of Molecular Functions in Proteins.
33928117 2021. Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production.
33912590 2021. Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19.
33659275 2021. Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin.
33537341 2020. Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line.
35558754 2022. Genetically Predicted Circulating Concentrations of Micronutrients and COVID-19 Susceptibility and Severity: A Mendelian Randomization Study.
33898353 2021. Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C).
32581799 2020. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.
33584343 2021. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies.
33574769 2021. Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32763915 2020. A molecular pore spans the double membrane of the coronavirus replication organelle.
32817270 2020. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.
32958580 2020. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.
32972994 2020. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
32691370 2021. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.
32355638 2020. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system.
34629295 2021. Differential roles of interferons in innate responses to mucosal viral infections.
33233531 2020. Immunogenetic Association Underlying Severe COVID-19.
34051372 2021. Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?
33422689 2021. Endothelial cells and SARS-CoV-2: An intimate relationship.
33232769 2021. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
35234623 2022. Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients.
33660566 2021. Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.
33842674 2021. In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment.
35632627 2022. Ubiquitous Micro-Modular Homologies among Genomes from Viruses to Bacteria to Human Mitochondrial DNA: Platforms for Recombination during Evolution?
34064525 2021. Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors.
33808906 2021. Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods.
33466921 2021. Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.
33396605 2020. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production.
34168732 2021. New perspectives on angiotensin-converting enzyme 2 and its related diseases.
34367930 2021. Hypotheses and facts for genetic factors related to severe COVID-19.
33998180 2021. Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice.
33178034 2020. Potential Role of Autonomic Dysfunction in Covid-19 Morbidity and Mortality.
33220345 2021. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
34175388 2021. Variants in AGTR2 gene in Maya people with COVID-19.
34778602 2021. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn.
34073716 2021. Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.
32884603 2020. Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
33788636 2021. A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2.
34425859 2021. Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.
35529075 2022. Wildfire-Induced Pollution and its Short-Term Impact on COVID-19 Cases and Mortality in California.
32844126 2020. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.
35224516 2022. A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors.
32827207 2020. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients.
34462158 2022. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
32750378 2020. A review of the main histopathological findings in coronavirus disease 2019.
35065665 2022. What's happening where when SARS-CoV-2 infects: are TLR7 and MAFB sufficient to explain patient vulnerability?
33425429 2020. Recent Insights into Cellular Crosstalk in Respiratory and Gastrointestinal Mucosal Immune Systems.
34910934 2021. Antigenic drift: Understanding COVID-19.
32433946 2020. Herd Immunity: Understanding COVID-19.
34410575 2021. COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells.
32658335 2020. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.
34001199 2021. Lung histopathological findings in COVID-19 disease - a systematic review.
35109926 2022. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.
34343725 2021. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19).
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
33079210 2021. Inflammasome formation in the lungs of patients with fatal COVID-19.
33756225 2021. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues.
33221169 2021. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
32738306 2020. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
35563515 2022. Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.
35628409 2022. Structure-Based Development of SARS-CoV-2 Spike Interactors.
35163504 2022. Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19.
35562935 2022. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.
35456997 2022. Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body.
34638539 2021. Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature.
34069441 2021. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
33807854 2021. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.
34209289 2021. Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives.
34208755 2021. More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells.
34299201 2021. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).
33668756 2021. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
34502033 2021. Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations.
33138181 2020. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
32823591 2020. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
33284413 2020. Endotoxemia and circulating bacteriome in severe COVID-19 patients.
34540148 2021. Bioinformatic analysis of the whole genome sequences of SARS-CoV-2 from Indonesia.
34957382 2022. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19.
33585805 2021. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without.
33997662 2021. Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids.
34189428 2021. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion.
34179733 2021. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.
34308276 2021. Sensor array and gas chromatographic detection of the blood serum volatolomic signature of COVID-19.
33015593 2020. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.
34467628 2021. Mast cells: Therapeutic targets for COVID-19 and beyond.
33960608 2021. Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders.
34614039 2021. virusMED: an atlas of hotspots of viral proteins.
35157798 2022. Strikingly Different Roles of SARS-CoV-2 Fusion Peptides Uncovered by Neutron Scattering.
34039006 2021. Conformational Ensembles of Noncoding Elements in the SARS-CoV-2 Genome from Molecular Dynamics Simulations.
34270232 2021. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket.
33051359 2020. Does SARS-CoV-2 Infect the Kidney?
33703942 2021. The invention of hypoxia.
35278433 2022. Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1.
34214498 2021. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.
32675285 2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.
32917722 2020. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
33122196 2020. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
33963094 2021. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response.
34098950 2021. Identification of COVID-19 B-cell epitopes with phage-displayed peptide library.
34275487 2021. The Infectious Disease Ontology in the age of COVID-19.
34741481 2022. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.
32785687 2020. Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.
32895779 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32542735 2021. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19.
33468620 2021. Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor.
34156227 2021. Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis.
33492309 2021. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
32422996 2020. Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site.
32918236 2020. An online repository of solvation thermodynamic and structural maps of SARS-CoV-2 targets.
34074197 2021. Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
34757384 2022. A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.
34357402 2021. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
33646265 2021. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
35574251 2022. Serum extracellular vesicles profiling is associated with COVID-19 progression and immune responses.
34982509 2022. Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection.
34874124 2021. Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles.
32568027 2020. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
32579100 2020. Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.
33242672 2021. Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.
34616852 2021. Inhaled [D-Ala(2)]-Dynorphin 1-6 Prevents Hyperacetylation and Release of High Mobility Group Box 1 in a Mouse Model of Acute Lung Injury.
33299899 2020. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2.
33337934 2020. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.
34467562 2022. Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).
35324008 2022. Reverse genetics systems for SARS-CoV-2.
33205830 2021. Coronapp: A web application to annotate and monitor SARS-CoV-2 mutations.
32374457 2020. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
34350099 2021. An Overview of the Perspective of Cellular Autophagy: Mechanism, Regulation, and the Role of Autophagy Dysregulation in the Pathogenesis of Diseases.
34780781 2022. Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen.
32422320 2020. p38 MAPK inhibition: A promising therapeutic approach for COVID-19.
35362781 2022. The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2.
33099199 2021. Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model.
34619427 2021. The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases.
33586189 2021. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.
32418199 2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
34196568 2021. Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface.
34196550 2021. Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
32787330 2020. Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike.
33085491 2020. Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands.
33274945 2020. Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2.
33269932 2020. Molecular Dynamics Reveals Complex Compensatory Effects of Ionic Strength on the Severe Acute Respiratory Syndrome Coronavirus 2 Spike/Human Angiotensin-Converting Enzyme 2 Interaction.
33662570 2021. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
32919067 2020. A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2.
35490763 2022. Distinguishing viruses responsible for influenza-like illness.
34478743 2021. Inverted repeats in coronavirus SARS-CoV-2 genome manifest the evolution events.
32627126 2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
34174875 2021. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
32427773 2020. Rescue therapy for severe COVID-19-associated acute respiratory distress syndrome with tissue plasminogen activator: A case series.
34669512 2022. Functional Effects of Cardiomyocyte Injury in COVID-19.
33257477 2021. A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
33158944 2021. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
33637603 2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.
33627397 2021. Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.
32434888 2020. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
32404529 2020. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
33835761 2021. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
32425000 2020. An overview of COVID-19.
33681537 2021. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis.
35608920 2022. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.
35133984 2022. Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection.
34357881 2021. Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses.
34747367 2021. Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19.
35368365 2021. Expression of ACE2 in the Intact and Acutely Injured Kidney.
34766101 2021. Urinary peptidomic profiles to address age-related disabilities: a prospective population study.
34562356 2021. Liberating host-virus knowledge from biological dark data.
34575070 2021. Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent.
33170317 2020. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
33907732 2021. Nanotraps for the containment and clearance of SARS-CoV-2.
33531391 2021. MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection.
32471829 2020. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
34149046 2021. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.
35262093 2022. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19.
35018385 2022. Integrin/TGF-beta1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity.
34401886 2021. Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination.
34642702 2021. A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program.
34031665 2021. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.
34013287 2021. Insights into genetic factors contributing to variability in SARS-CoV-2 susceptibility and COVID-19 disease severity.
33688686 2021. IL-13 is a driver of COVID-19 severity.
34268522 2021. Decoding Clinical Biomarker Space of COVID-19: Exploring Matrix Factorization-based Feature Selection Methods.
33655273 2021. A catalog of associations between rare coding variants and COVID-19 outcomes.
33880488 2021. Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.
32869043 2020. The unintended consequences of inconsistent pandemic control policies.
33200144 2020. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.
33269361 2020. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19.
32511639 2020. A single-cell atlas of the peripheral immune response to severe COVID-19.
33349792 2021. Essential interpretations of bioinformatics in COVID-19 pandemic.
35381232 2022. Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients.
34357361 2021. Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection.
33881539 2021. Chemistry and biology of ferritin.
34547443 2022. Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.
34029715 2021. COVID-19 related interdisciplinary methods: Preventing errors and detecting research opportunities.
34738157 2021. Comparative Host-Pathogen Interaction Analyses of SARS-CoV2 and Aspergillus fumigatus, and Pathogenesis of COVID-19-Associated Aspergillosis.
34870573 2021. SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity.
34861346 2022. Machine learning based predictive model and systems-level network of host-microbe interactions in post-COVID-19 mucormycosis.
33373693 2021. Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival.
34192695 2022. CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.
35234489 2022. VPipe: an Automated Bioinformatics Platform for Assembly and Management of Viral Next-Generation Sequencing Data.
34787497 2021. SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021.
35194246 2022. Genetic Engineering Systems to Study Human Viral Pathogens from the Coronaviridae Family.
34638137 2022. The Neighborhood of the Spike Gene Is a Hotspot for Modular Intertypic Homologous and Nonhomologous Recombination in Coronavirus Genomes.
33585889 2021. Global Patterns of Recombination across Human Viruses.
32289821 2020. Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense.
35596055 2022. A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.
35594856 2022. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells.
33743061 2021. Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy.
34608263 2022. The acid sphingomyelinase/ceramide system in COVID-19.
34385600 2021. Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms.
34487431 2021. Tensor-structured decomposition improves systems serology analysis.
35408447 2022. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
35163948 2022. DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design.
34500777 2021. Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase.
33437534 2020. Angstrom- and Nano-scale Pore-Based Nucleic Acid Sequencing of Current and Emergent Pathogens.
34313463 2021. Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds.
34542296 2021. Detection of SARS-CoV-2 with Solid-State CRISPR-Cas12a-Assisted Nanopores.
33391623 2020. Manganese nanodepot augments host immune response against coronavirus.
34632381 2021. OnTheFly(2.0): a text-mining web application for automated biomedical entity recognition, document annotation, network and functional enrichment analysis.
35508460 2022. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
35246509 2022. Evolution of the SARS-CoV-2 spike protein in the human host.
35236847 2022. Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells.
35301316 2022. RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection.
35078982 2022. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.
35058437 2022. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.
35017512 2022. Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2.
35194049 2022. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core.
33990585 2021. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions.
33782395 2021. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.
34103506 2021. Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1.
34099703 2021. Assessment of protein-protein interfaces in cryo-EM derived assemblies.
34168138 2021. The architecture of the SARS-CoV-2 RNA genome inside virion.
34226537 2021. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.
33479198 2021. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.
33431842 2021. Stabilizing the closed SARS-CoV-2 spike trimer.
33087721 2020. Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32709887 2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
35042228 2022. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant.
33589825 2021. Humoral signatures of protective and pathological SARS-CoV-2 infection in children.
33727702 2021. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.
32669681 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
32341570 2020. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks.
33514944 2021. Engineering SARS-CoV-2 using a reverse genetic system.
33824489 2021. Emerging concepts in the science of vaccine adjuvants.
33824483 2021. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
33214719 2021. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.
32355328 2020. Impaired interferon signature in severe COVID-19.
32606379 2020. The network effect: studying COVID-19 pathology with the Human Cell Atlas.
32737467 2020. A thermostable, closed SARS-CoV-2 spike protein trimer.
32699321 2020. Controlling the SARS-CoV-2 spike glycoprotein conformation.
32225175 2020. Structural basis of receptor recognition by SARS-CoV-2.
32015507 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin.
34780863 2021. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
33053430 2020. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
32532983 2020. Advice from a systems-biology model of the corona epidemics.
34747468 2022. HumanNet v3: an improved database of human gene networks for disease research.
34643704 2022. ESC: a comprehensive resource for SARS-CoV-2 immune escape variants.